TWI746286B - Hydrogel composition and hydrogel contact lens - Google Patents

Hydrogel composition and hydrogel contact lens Download PDF

Info

Publication number
TWI746286B
TWI746286B TW109141266A TW109141266A TWI746286B TW I746286 B TWI746286 B TW I746286B TW 109141266 A TW109141266 A TW 109141266A TW 109141266 A TW109141266 A TW 109141266A TW I746286 B TWI746286 B TW I746286B
Authority
TW
Taiwan
Prior art keywords
molecule
weight
composition according
cyclodextrin
rotaxane
Prior art date
Application number
TW109141266A
Other languages
Chinese (zh)
Other versions
TW202138471A (en
Inventor
吳欣怡
李崇維
陳君涵
張漢宜
Original Assignee
晶碩光學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 晶碩光學股份有限公司 filed Critical 晶碩光學股份有限公司
Priority to CN202011398197.0A priority Critical patent/CN113527581A/en
Priority to JP2021058460A priority patent/JP7140869B2/en
Priority to US17/227,381 priority patent/US20210315807A1/en
Priority to EP21167820.6A priority patent/EP3895693A1/en
Publication of TW202138471A publication Critical patent/TW202138471A/en
Application granted granted Critical
Publication of TWI746286B publication Critical patent/TWI746286B/en

Links

Images

Abstract

A hydrogel composition includes: a hydrophilic monomer, a cross-linking agent, an initiator, and a rotaxane molecule. The hydrophilic monomer is 60 parts by weight to 99.85 parts by weight, the cross-linking agent is 0.01 part by weight to 1 part by weight, the initiator is 0.01 part by weight to 2 parts by weight, and the rotaxane molecule is 0.1 parts by weight to 15 parts by weight. The rotaxane molecule includes at least one cyclic molecule and at least one linear molecule penetrating through the cyclic molecule in a string shape. The weight ratio of the rotaxane molecule to the hydrophilic monomer is between 1: 6 and 1:99. The present disclosure further provides a hydrogel contact lens, which is formed by the hydrogel composition. The present invention also discloses a hydrogel contact lens.

Description

水膠組成物及水膠鏡片Water gel composition and water gel lens

本發明涉及一種水膠組成物,特別是涉及一種水膠組成物及水膠鏡片,其能負載及緩釋活性成分。The present invention relates to a water gel composition, in particular to a water gel composition and a water gel lens, which can load and slow-release active ingredients.

過去數十年來,眼用的藥物(或活性成分)遞送一直是眼科學家很重要的挑戰。過去普遍使用眼藥水局部滴劑的供藥方式對人體的眼部進行治療。然而,以此供藥方式,藥物滴入人體的眼部後瞬間會被稀釋,並且藥物容易從淚竅中排出。藥物在人體的眼部中的滯留時間短暫,從而導致治療效果不佳的問題產生。因此,需考慮提高藥物的使用頻率或提升藥物的劑量,但卻反而增加藥物的副作用風險,故上述給藥方式並非為良好的給藥方式。The delivery of ophthalmic drugs (or active ingredients) has been an important challenge for ophthalmologists for the past few decades. In the past, topical eye drops were commonly used to treat the eyes of the human body. However, in this way of supplying medicine, the medicine will be diluted instantly after being dripped into the eyes of the human body, and the medicine will be easily discharged from the tear orifice. The retention time of the drug in the eyes of the human body is short, which leads to the problem of poor therapeutic effect. Therefore, it is necessary to consider increasing the frequency of drug use or increasing the dose of the drug, but it increases the risk of side effects of the drug. Therefore, the above-mentioned administration method is not a good administration method.

於是,本發明人有感上述缺失之可改善,乃特潛心研究並配合學理之運用,終於提出一種設計合理且有效改善上述缺失之本發明。Therefore, the inventor feels that the above-mentioned deficiency can be improved, and with great concentration of research and the application of scientific theory, finally proposes an invention with a reasonable design and effective improvement of the above-mentioned deficiency.

本發明所要解決的技術問題在於,針對現有技術的不足提供一種水膠組成物及水膠鏡片。The technical problem to be solved by the present invention is to provide a water gel composition and a water gel lens in view of the deficiencies of the prior art.

為了解決上述的技術問題,本發明所採用的其中一技術方案是提供一種水膠組成物,其包括:一親水性單體,為60重量份至99.85重量份;一交聯劑,為0.01重量份至1重量份;一起始劑,為0.01重量份至2重量份;以及一輪烷分子(rotaxane),為0.1重量份至15重量份;其中,所述輪烷分子包含有至少一環狀分子及以穿串狀貫通至少一所述環狀分子的至少一直鏈狀分子;其中,所述輪烷分子與所述親水性單體的重量比例介於1:6至1:99之間。In order to solve the above-mentioned technical problems, one of the technical solutions adopted by the present invention is to provide a hydrogel composition, which comprises: a hydrophilic monomer of 60 parts by weight to 99.85 parts by weight; a crosslinking agent of 0.01 parts by weight Parts to 1 part by weight; an initiator, 0.01 parts by weight to 2 parts by weight; and a rotaxane molecule, 0.1 parts by weight to 15 parts by weight; wherein the rotaxane molecule contains at least one cyclic molecule And at least linear molecules passing through at least one of the cyclic molecules in a string; wherein the weight ratio of the rotaxane molecule to the hydrophilic monomer is between 1:6 to 1:99.

為了解決上述的技術問題,本發明所採用的另外一技術方案是提供一種水膠鏡片,包括:一鏡片主體,其係由如上所述的水膠組成物所形成。In order to solve the above technical problem, another technical solution adopted by the present invention is to provide a water gel lens, including: a lens body formed by the above water gel composition.

本發明的其中一有益效果在於,本發明所提供的用於製備水膠鏡片的水膠組成物及水膠鏡片,其能通過在水膠組成物中導入輪烷分子(rotaxane)的技術方案,以使得最終形成的水膠鏡片能具有負載及緩釋活性成分的效果。One of the beneficial effects of the present invention is that the water gel composition and the water gel lens for preparing the water gel lens provided by the present invention can adopt the technical solution of introducing rotaxane molecules into the water gel composition, So that the final formed hydrocolloid lens can have the effect of loading and slow-release of active ingredients.

值得一提的是,本發明的水膠鏡片在導入輪烷分子的情況下,不僅具有負載及緩釋活性成分的效果,並且仍然能夠維持隱形眼鏡鏡片所需的特性,如:鏡片基弧(base curve,BC)、鏡片中心厚度(center thickness,CT)、鏡片直徑(diameter,DIA)、折射率、可見光穿透率或動態接觸角…等。It is worth mentioning that when the rotaxane molecule is introduced, the hydrocolloid lens of the present invention not only has the effect of loading and slow-release of the active ingredient, but also can maintain the required characteristics of the contact lens, such as the lens base curve ( base curve, BC), lens center thickness (CT), lens diameter (diameter, DIA), refractive index, visible light transmittance or dynamic contact angle... etc.

為使能更進一步瞭解本發明的特徵及技術內容,請參閱以下有關本發明的詳細說明與圖式,然而所提供的圖式僅用於提供參考與說明,並非用來對本發明加以限制。In order to further understand the features and technical content of the present invention, please refer to the following detailed description and drawings about the present invention. However, the provided drawings are only for reference and description, and are not used to limit the present invention.

以下是通過特定的具體實施例來說明本發明所公開有關“水膠組成物及水膠鏡片”的實施方式,本領域技術人員可由本說明書所公開的內容瞭解本發明的優點與效果。本發明可通過其他不同的具體實施例加以施行或應用,本說明書中的各項細節也可基於不同觀點與應用,在不背離本發明的構思下進行各種修改與變更。以下的實施方式將進一步詳細說明本發明的相關技術內容,但所公開的內容並非用以限制本發明的保護範圍。另外,本文中所使用的術語“或”,應視實際情況可能包括相關聯的列出項目中的任一個或者多個的組合。The following are specific examples to illustrate the implementation of the "water gel composition and water gel lens" disclosed in the present invention. Those skilled in the art can understand the advantages and effects of the present invention from the content disclosed in this specification. The present invention can be implemented or applied through other different specific embodiments, and various details in this specification can also be based on different viewpoints and applications, and various modifications and changes can be made without departing from the concept of the present invention. The following embodiments will further describe the related technical content of the present invention in detail, but the disclosed content is not intended to limit the protection scope of the present invention. In addition, the term "or" used in this document may include any one or a combination of more of the associated listed items depending on the actual situation.

於本文中,除非內文中對於冠詞有所特別限定,否則“一”與“所述”可泛指單一個或多個。將進一步理解的是,本文中所使用之“包含”、“包括”、“具有”及相似詞彙,指明其所記載的特徵、區域、整數、步驟、操作、元件與/或組件,但不排除其所述或額外的其一個或多個其它特徵、區域、整數、步驟、操作、元件、組件,與/或其中之群組。In this article, unless the article is specifically limited in the context, "a" and "the" can generally refer to a single one or more. It will be further understood that the "including", "including", "having" and similar words used in this text indicate the recorded features, regions, integers, steps, operations, elements and/or components, but do not exclude The described or additional one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.

經由先前技術所提及的技術缺陷可得知,過去數十年來,眼用的藥物(或活性成分)遞送一直是眼科學家很重要的挑戰。過去普遍使用眼藥水局部滴劑的供藥方式對人體的眼部進行治療。然而,以此供藥方式,藥物滴入人體的眼部後瞬間會被稀釋,並且藥物容易從淚竅中排出。藥物在人體的眼部中的滯留時間短暫,從而導致治療效果不佳的問題產生。因此,需考慮提高藥物的使用頻率或提升藥物的劑量,但卻反而增加藥物的副作用風險,故上述給藥方式並非為良好的給藥方式。According to the technical shortcomings mentioned in the prior art, the delivery of ophthalmic drugs (or active ingredients) has been a very important challenge for ophthalmologists in the past decades. In the past, topical eye drops were commonly used to treat the eyes of the human body. However, in this way of supplying medicine, the medicine will be diluted instantly after being dripped into the eyes of the human body, and the medicine will be easily discharged from the tear orifice. The retention time of the drug in the eyes of the human body is short, which leads to the problem of poor therapeutic effect. Therefore, it is necessary to consider increasing the frequency of drug use or increasing the dose of the drug, but it increases the risk of side effects of the drug. Therefore, the above-mentioned administration method is not a good administration method.

為了改善上述技術缺陷,本發明的目的之一在於,提供一種新型態的水膠鏡片,其為活性成分運輸載體的策略。本發明藉由新型態的水膠鏡片搭配活性成分的緩釋技術,成為新的活性成分遞送模式。本發明的技術能使活性成分保留於隱形眼鏡上,而延長活性成分在眼睛上的停留時間,提高活性成分的利用率,藉此延長配戴者的舒適度,甚至達到長效的保養效果。In order to improve the above technical drawbacks, one of the objectives of the present invention is to provide a new type of hydrogel lens, which is a strategy for the transportation of active ingredients. The present invention has become a new delivery mode of active ingredients by using a new type of hydrogel lens with slow-release technology of active ingredients. The technology of the present invention can keep the active ingredients on the contact lens, prolong the residence time of the active ingredients on the eyes, improve the utilization rate of the active ingredients, thereby prolong the comfort of the wearer, and even achieve long-term maintenance effects.

[水膠組成物][Water glue composition]

為了實現上述目的,本發明實施例提供一種用於製備水膠鏡片的水膠組成物。所述水膠組成物包含有:一親水性單體(hydrophilic monomer)、一交聯劑(crosslinker)、一起始劑(initiator)及一輪烷分子(rotaxane)。In order to achieve the above objective, embodiments of the present invention provide a water gel composition for preparing water gel lenses. The hydrogel composition includes: a hydrophilic monomer, a crosslinker, an initiator, and a rotaxane.

在用量方面,所述親水性單體的用量優選為60重量份至99.85重量份、且特優選為68.88重量份至99.85重量份。所述交聯劑的用量優選為0.01重量份至1重量份、且特優選為0.04重量份至0.57重量份。所述起始劑的用量優選為0.01重量份至2重量份、且特優選為0.05重量份至0.72重量份。並且,所述輪烷分子的用量通常為0.1重量份至15重量份、優選為0.1重量份至12重量份、且特優選為0.5重量份至8重量份。In terms of amount, the amount of the hydrophilic monomer is preferably 60 parts by weight to 99.85 parts by weight, and particularly preferably 68.88 parts by weight to 99.85 parts by weight. The amount of the crosslinking agent is preferably 0.01 part by weight to 1 part by weight, and particularly preferably 0.04 part by weight to 0.57 part by weight. The amount of the initiator is preferably 0.01 parts by weight to 2 parts by weight, and particularly preferably 0.05 parts by weight to 0.72 parts by weight. In addition, the amount of the rotaxane molecule is usually 0.1 parts by weight to 15 parts by weight, preferably 0.1 parts by weight to 12 parts by weight, and particularly preferably 0.5 parts by weight to 8 parts by weight.

為了讓輪烷分子能均勻地分散在水膠組成物中且能發揮預期的效果,所述輪烷分子與所述親水性單體的重量比例具有一特定的比例範圍。舉例來說,所述輪烷分子與所述親水性單體的重量比例通常是介於1:6至1:99之間、優選是介於1:11至1:99之間、且特優選是介於1:14至1:74之間,但本發明不受限於此。In order to allow the rotaxane molecules to be uniformly dispersed in the hydrogel composition and to exert the expected effect, the weight ratio of the rotaxane molecules to the hydrophilic monomer has a specific ratio range. For example, the weight ratio of the rotaxane molecule to the hydrophilic monomer is usually between 1:6 and 1:99, preferably between 1:11 and 1:99, and particularly preferably It is between 1:14 and 1:74, but the present invention is not limited to this.

若輪烷分子與親水性單體的重量比例低於上述比例範圍的下限值(如:1:1),則輪烷分子可能因添加比例過高而無法均勻地分散在水膠組成物中,從而使得最終成形的水膠鏡片具有不佳的品質(如:折射率不佳或光透率不佳)。If the weight ratio of the rotaxane molecule to the hydrophilic monomer is lower than the lower limit of the above ratio range (such as 1:1), the rotaxane molecule may not be uniformly dispersed in the hydrogel composition due to the high addition ratio , So that the final formed water gel lens has poor quality (such as: poor refractive index or poor light transmittance).

反之,若輪烷分子與親水性單體的重量比例高於上述範圍的上限值(如:1:200),則輪烷分子可能因添加比例過低而無法在最終成形的水膠鏡片中發揮預期的效果(如:有效地負載及緩釋活性成分)。Conversely, if the weight ratio of the rotaxane molecule to the hydrophilic monomer is higher than the upper limit of the above range (such as 1:200), the rotaxane molecule may not be included in the final formed hydrogel lens due to the low addition ratio. Play the expected effect (such as effective loading and slow release of active ingredients).

以下接著介紹本發明實施例的水膠組成物中的各個成分的材料種類。The following describes the material types of each component in the water gel composition of the embodiment of the present invention.

所述親水性單體的分子結構中優選是具有乙烯基(vinyl group)、乙醯基(acetyl group)、丙烯基(propenyl group)或丙烯醯基(acryl group)。The molecular structure of the hydrophilic monomer preferably has a vinyl group, an acetyl group, a propenyl group, or an acryl group.

在本發明的多個實施方式中,所述親水性單體是選自由N-乙烯基吡咯烷酮(N-vinyl pyrrolidone,NVP)、2-羥基乙基甲基丙烯酸酯(2-hydroxyethyl methacrylate,HEMA)、甲基丙烯酸(methacrylic acid,MAA)、甲基丙烯酸甲酯(methyl methacrylate,MMA)、丙烯酸(acrylic acid,AAc)、N,N-二甲基丙烯醯胺(N,N-dimethyl acrylamide,DMA)、2-甲基-2-丙烯酸-2,3-二羥基丙酯(2,3-dihydroxypropyl methacrylate,GMMA)、N,N-二甲基甲基丙烯醯胺(N,N-dimethyl methacrylamide)、及N-乙基-N-甲基乙醯胺(N-vinyl-N-methyl acetamide)所組成的材料群組的至少其中之一。In various embodiments of the present invention, the hydrophilic monomer is selected from N-vinyl pyrrolidone (NVP), 2-hydroxyethyl methacrylate (HEMA) , Methacrylic acid (MAA), methyl methacrylate (MMA), acrylic acid (AAc), N,N-dimethyl acrylamide (DMA) ), 2-methyl-2-acrylic acid-2,3-dihydroxypropyl ester (2,3-dihydroxypropyl methacrylate, GMMA), N,N-dimethyl methacrylamide (N,N-dimethyl methacrylamide) , And at least one of the material group consisting of N-vinyl-N-methyl acetamide (N-vinyl-N-methyl acetamide).

在本發明的多個實施方式中,所述水膠組成物更包含有一矽膠化合物,所述矽膠化合物是選自由一矽單體、一矽高聚合物及一矽預聚物所組成的材料群組的至少其中之一。藉此,最終形成的水膠鏡片可以為一矽水膠鏡片。In various embodiments of the present invention, the water gel composition further includes a silicone compound, and the silicone compound is selected from the group consisting of a silicon monomer, a silicon polymer, and a silicon prepolymer At least one of the group. In this way, the finally formed water gel lens can be a silicon water gel lens.

在本發明的多個實施方式中,所述交聯劑是選自由乙烯基乙二醇基二甲基丙烯酸酯(ethylene glycol dimethacrylate)、二乙烯基乙二醇基二甲基丙烯酸酯(diethylene glycol dimethacrylate)、三乙烯基乙二醇基二甲基丙烯酸酯(triethylene glycol dimethacrylate)、四乙烯基乙二醇基二甲基丙烯酸酯(tetraethylene glycol dimethacrylate)、烯丙基甲基丙烯酸酯(allyl methacrylate)、三乙烯基乙二醇基二烯丙基醚(triethylene glycol dially ether)、四乙烯基乙二醇基二烯丙基醚(tetraethylene glycol dially ether)、及三羥甲基丙烷三甲基丙烯酸酯(1,1,1-trimethylolpropane trimethacrylate)所組成的材料群組的至少其中之一。In various embodiments of the present invention, the crosslinking agent is selected from the group consisting of ethylene glycol dimethacrylate and diethylene glycol dimethacrylate. dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate , Triethylene glycol dially ether, tetraethylene glycol dially ether, and trimethylolpropane trimethacrylate (1,1,1-trimethylolpropane trimethacrylate) at least one of the material group.

在本發明的多個實施方式中,所述起始劑為光起始劑。In various embodiments of the present invention, the initiator is a photoinitiator.

所述光起始劑是選自由雙(1-(2,4-二氟苯基)-3-吡咯基)二茂鈦(bis(2,6-difluoro-3-(1-hydropyrro-1-yl)- phenyl)titanocene)、苯基雙(2,4,6-三甲基苯甲酰基)氧化膦(phenylbis-(2,4,6-trimethylbenzoyl)-phosphine oxide)及2-羥基-2-甲基-1-苯基-1-丙酮(2-hydroxy-2-methyl-1-phenyl-1-porpanone)所組成的材料群組的至少其中之一。The photoinitiator is selected from bis(1-(2,4-difluorophenyl)-3-pyrrolyl) titanocene (bis(2,6-difluoro-3-(1-hydropyrro-1- yl)- phenyl)titanocene), phenylbis-(2,4,6-trimethylbenzoyl)-phosphine oxide and 2-hydroxy-2- At least one of the material group consisting of 2-hydroxy-2-methyl-1-phenyl-1-porpanone.

進一步地說,所述輪烷分子包含有至少一環狀分子(cyclic molecule)及至少一直鏈狀分子(linear molecule),並且至少一所述直鏈狀分子以穿串狀貫通至少一所述環狀分子。More specifically, the rotaxane molecule includes at least one cyclic molecule and at least a linear molecule, and at least one linear molecule penetrates through at least one cyclic molecule in a string.状 Molecule.

為了讓輪烷分子能有效地負載及緩釋活性成分,所述環狀分子與直鏈狀分子的重量比例具有一特定的比例範圍。舉例來說,至少一所述環狀分子與至少一所述直鏈狀分子的重量比例優選是介於1:1至50:1之間、且特優選是介於5:1至35:1之間。In order to allow the rotaxane molecule to effectively load and release the active ingredient, the weight ratio of the cyclic molecule to the linear molecule has a specific ratio range. For example, the weight ratio of at least one said cyclic molecule to at least one said linear molecule is preferably between 1:1 and 50:1, and particularly preferably between 5:1 and 35:1. between.

也就是說,在所述輪烷分子中,所述環狀分子的數量通常為多個,所述直鏈狀分子的數量通常為一個,並且一個所述直鏈狀分子是貫通至多個所述環狀分子中。That is, in the rotaxane molecule, the number of the cyclic molecules is usually multiple, the number of the linear molecule is usually one, and one linear molecule penetrates to a plurality of the In the cyclic molecule.

藉此,所述環狀分子與直鏈狀分子之間能形成有足夠的空間,以負載有效劑量的活性成分。再者,所述環狀分子與所述直鏈狀分子之間呈動態結構,以使得所述輪烷分子能實現緩慢釋放活性成分的效果。Thereby, a sufficient space can be formed between the cyclic molecule and the linear molecule to load an effective dose of the active ingredient. Furthermore, there is a dynamic structure between the cyclic molecule and the linear molecule, so that the rotaxane molecule can achieve the effect of slowly releasing the active ingredient.

若所述環狀分子與直鏈狀分子的重量比例超出上述特定的比例範圍,則所述輪烷分子在負載及緩釋活性成分的效果上將可能變得不理想。If the weight ratio of the cyclic molecule to the linear molecule exceeds the above-mentioned specific ratio range, the effect of the rotaxane molecule on loading and slow-release of the active ingredient may become unsatisfactory.

在材料種類方面,所述環狀分子可以例如是環糊精(cyclodextrin)或其衍生物,但本發明不受限於此。In terms of material types, the cyclic molecule may be, for example, cyclodextrin (cyclodextrin) or a derivative thereof, but the present invention is not limited thereto.

在本發明的多個實施方式中,所述環糊精是選自由α-環糊精(α-cyclodextrin)、β-環糊精(β-cyclodextrin)、γ-環糊精(γ-cyclodextrin)、羥丙基-β-環糊精(hydroxypropyl-β-cyclodextrin)、(2-羥丙基)-γ-環糊精((2-hydroxypropyl)-γ-cyclodextrin)、磺丁基醚-β-環糊精(sulfobutylether-β-cyclodextrin)及甲基-β-環糊精(methyl-β-cyclodextrin)所組成的材料群組的至少其中之一。In various embodiments of the present invention, the cyclodextrin is selected from α-cyclodextrin (α-cyclodextrin), β-cyclodextrin (β-cyclodextrin), γ-cyclodextrin (γ-cyclodextrin) , Hydroxypropyl-β-cyclodextrin (hydroxypropyl-β-cyclodextrin), (2-hydroxypropyl)-γ-cyclodextrin ((2-hydroxypropyl)-γ-cyclodextrin), sulfobutyl ether-β- At least one of the material group consisting of cyclodextrin (sulfobutylether-β-cyclodextrin) and methyl-β-cyclodextrin (methyl-β-cyclodextrin).

再者,所述環狀分子也可以例如是冠醚(crown ether)或其衍生物,但本發明不受限於此。Furthermore, the cyclic molecule may also be, for example, a crown ether (crown ether) or a derivative thereof, but the present invention is not limited thereto.

在本發明的多個實施方式中,所述冠醚是選自由12-冠-4(12-crown-4)、15-冠-5(15-crown-5)、18-冠-6(18-crown-6)、苯並-18-冠-6(benzo-18-crown-6)、苯並15-冠-5(benzo-15-crown-5)、二環己基-18-冠-6(dicyclohexyl-18-crown-6)、2-(羥甲基)-12-冠-4-醚(2-(hydroxymethyl)-12-crown-4-ether)、2-(羥甲基)-15-冠-5-醚(2-(hydroxymethyl)-15-crown-5-ether)及2-(羥甲基)-18-冠-6-醚(2-(hydroxymethyl)-18-crown-6-ether)所組成的材料群組的至少其中之一。In various embodiments of the present invention, the crown ether is selected from 12-crown-4 (12-crown-4), 15-crown-5 (15-crown-5), 18-crown-6 (18 -crown-6), benzo-18-crown-6 (benzo-18-crown-6), benzo-15-crown-5 (benzo-15-crown-5), dicyclohexyl-18-crown-6 (Dicyclohexyl-18-crown-6), 2-(hydroxymethyl)-12-crown-4-ether, 2-(hydroxymethyl)-15 -Crown-5-ether (2-(hydroxymethyl)-15-crown-5-ether) and 2-(hydroxymethyl)-18-crown-6-ether (2-(hydroxymethyl)-18-crown-6- At least one of the material groups formed by ether).

進一步地說,所述直鏈狀分子是選自由聚乙二醇(polyethylene glycol,PEG)、聚乙烯醇(polyvinyl alcohol,PVA)及聚丙二醇(polypropylene glycol,PPG)所組成的材料群組的至少其中之一。Furthermore, the linear molecule is at least selected from the group consisting of polyethylene glycol (PEG), polyvinyl alcohol (PVA) and polypropylene glycol (PPG). one of them.

其中,聚乙二醇具有如式(1)之結構:

Figure 02_image001
(1) Among them, polyethylene glycol has a structure such as formula (1):
Figure 02_image001
(1)

其中,聚乙烯醇具有如式(2)之結構:

Figure 02_image003
(2) Among them, polyvinyl alcohol has a structure such as formula (2):
Figure 02_image003
(2)

其中,聚丙二醇具有如式(3)之結構:

Figure 02_image005
(3) Among them, polypropylene glycol has a structure such as formula (3):
Figure 02_image005
(3)

其中,n優選為大於4的正整數、且特優選為介於100至6,000的正整數。再者,所述直鏈狀分子的平均分子量優選是介於200至20,000之間,但本發明不受限於此。Among them, n is preferably a positive integer greater than 4, and particularly preferably a positive integer between 100 and 6,000. Furthermore, the average molecular weight of the linear molecule is preferably between 200 and 20,000, but the present invention is not limited thereto.

值得一提的是,本發明的目的之一在於,在用於製備水膠鏡片的水膠組成物中導入“輪烷分子”,以藉助輪烷分子能負載活性成分的特性,使得水膠鏡片能搭載包合技術,而具有負載及緩釋活性成分的效果。It is worth mentioning that one of the objectives of the present invention is to introduce "rotaxane molecules" into the water gel composition used to prepare the water gel lens, so that the rotaxane molecule can load the active ingredients to make the water gel lens It can be equipped with inclusion technology, and has the effect of loading and slow-release of active ingredients.

其中,上述“包合技術”是將活性成分(或稱目標物)包嵌於環狀分子中,以使得活性成分能呈現穩定的狀態。再者,環狀分子能搭配直鏈狀分子形成輪烷分子,而實現緩慢釋放活性成分的目的。Among them, the above-mentioned "inclusion technology" is to embed the active ingredient (or the target substance) in the cyclic molecule, so that the active ingredient can assume a stable state. Furthermore, cyclic molecules can be combined with linear molecules to form rotaxane molecules to achieve the purpose of slow release of active ingredients.

換個角度說,“包合技術”是指一種分子被包嵌於另一種分子的空穴結構内,以形成包合物(inclusion compound)的技術。其中,包合物是由主分子(host molecule)及客體分子(guest molecule)加合組成。並且,主分子具有較大的空穴結構,其足以將客體分子容納在内,以形成分子囊(molecule capsule)。From another perspective, "inclusion technology" refers to a technology in which a molecule is embedded in the cavity structure of another molecule to form an inclusion compound. Among them, the inclusion compound is composed of the addition of a host molecule and a guest molecule. In addition, the host molecule has a relatively large cavity structure, which is enough to contain the guest molecules to form a molecular capsule.

在本發明的一具體實施例中,所述輪烷分子中的環狀分子為環糊精,並且直鏈狀分子為聚乙二醇(PEG),但本發明不受限於此。In a specific embodiment of the present invention, the cyclic molecule in the rotaxane molecule is cyclodextrin, and the linear molecule is polyethylene glycol (PEG), but the present invention is not limited thereto.

其中,環糊精的分子形狀如同輪胎,每個葡萄糖殘基的C-2及C-3原子上的二級羥基是位於環糊精圓環的分子一端,其直徑稍大,而C-6上的一級羥基則是位於環糊精圓環的分子另一端,直徑稍小。因此,環糊精分子內部為一個疏水性空穴結構,其能提供脂溶性活性成分(如:薄荷醇、維他命E醋酸酯)進入且負載於其內。Among them, the molecular shape of cyclodextrin is like a tire. The secondary hydroxyl group on the C-2 and C-3 atoms of each glucose residue is located at one end of the molecule of the cyclodextrin ring, and its diameter is slightly larger, while C-6 The upper first hydroxyl group is located at the other end of the cyclodextrin ring and has a slightly smaller diameter. Therefore, the inside of the cyclodextrin molecule is a hydrophobic cavity structure, which can provide fat-soluble active ingredients (such as menthol, vitamin E acetate) to enter and be loaded into it.

以下為三種主要類型環糊精的化學結構。 環糊精類型 化學結構 α-環糊精(α-cyclodextrin)

Figure 02_image007
β-環糊精(β-cyclodextrin)
Figure 02_image009
γ-環糊精(γ-cyclodextrin)
Figure 02_image011
The following are the chemical structures of the three main types of cyclodextrins. Cyclodextrin type Chemical structure α-cyclodextrin (α-cyclodextrin)
Figure 02_image007
β-cyclodextrin (β-cyclodextrin)
Figure 02_image009
γ-cyclodextrin (γ-cyclodextrin)
Figure 02_image011

當環糊精與脂溶性活性成分一起溶於溶劑作用時,所述脂溶性活性成分通常會進入環糊精的疏水性空穴結構內,環糊精會利用其外圍的羥基(-OH基)與水溶液或極性大的溶液(如:親水性單體或隱形眼鏡保養液)作用,以達到增加脂溶性活性成分的溶解度的效果。When the cyclodextrin and the fat-soluble active ingredient are dissolved in a solvent together, the fat-soluble active ingredient usually enters the hydrophobic cavity structure of the cyclodextrin, and the cyclodextrin utilizes its peripheral hydroxyl group (-OH group) It can be used with aqueous solutions or highly polar solutions (such as hydrophilic monomers or contact lens maintenance solutions) to increase the solubility of fat-soluble active ingredients.

除了將環糊精與脂溶性活性成分形成複合物,以增加其溶解度外,複合物再搭配直鏈狀分子(如:PEG)作用後,可再形成輪烷分子,以利穩定地釋放負載的活性成分。In addition to forming a complex of cyclodextrin and fat-soluble active ingredients to increase its solubility, the complex can be combined with linear molecules (such as PEG) to form rotaxane molecules to facilitate stable release of the loaded Active ingredient.

更具體地說,上述輪烷分子是通過環狀分子與直鏈狀分子之間的超分子作用力而形成。輪烷分子包含有一個或幾個環狀分子(輪)及一個直鏈狀分子(軸)。直鏈狀分子及環狀分子通過弱相互作用“力學鍵/機械鍵”(mechanical bond)相連,而不是通過強的共價鍵或配位鍵連接。因此,這種超分子聚合物具有較小的穩定性、且具有動態的結構,其適合負載諸如:小分子藥物、蛋白藥物或基因…等活性成分。More specifically, the above-mentioned rotaxane molecule is formed by the supramolecular force between a cyclic molecule and a linear molecule. The rotaxane molecule contains one or several cyclic molecules (wheels) and one linear molecule (shaft). Linear molecules and cyclic molecules are connected by weak interaction "mechanical bonds" instead of strong covalent bonds or coordination bonds. Therefore, this supramolecular polymer has less stability and a dynamic structure, which is suitable for loading active ingredients such as small molecule drugs, protein drugs, or genes.

值得一提的是,在輪烷分子負載活性成分的能力方面,本申請發明人在學術文獻上也做了許多研究。It is worth mentioning that the inventor of the present application has also done a lot of research in academic literature regarding the ability of rotaxane molecules to load active ingredients.

舉例來說,文獻Pol. J. Chem. Tech. 2016 18(3) 110-116指出,環糊精能夠有效地負載薄荷醇。文獻J Fluoresc. 2007 17 265-270指出,羥丙基-β-環糊精(hydroxypropyl-β-cyclodextrin,HP-β-CD)能夠有效地負載維生素B12(Vitamin B12)。另外,文獻J Agric Food Chem. 2017 65(26) 5404-5412中也指出,羥丙基-β-環糊精(hydroxypropyl-β-cyclodextrin,HP-β-CD)能夠有效地負載維生素E(Vitamin E),進而使得維生素E在水中的溶解度增加。For example, the document Pol. J. Chem. Tech. 2016 18(3) 110-116 pointed out that cyclodextrin can effectively load menthol. Document J Fluoresc. 2007 17 265-270 pointed out that hydroxypropyl-β-cyclodextrin (HP-β-CD) can effectively load vitamin B12 (Vitamin B12). In addition, the document J Agric Food Chem. 2017 65(26) 5404-5412 also pointed out that hydroxypropyl-β-cyclodextrin (HP-β-CD) can effectively load vitamin E (Vitamin E), which in turn increases the solubility of vitamin E in water.

另外值得一提的是,如上文所述,所述輪烷分子與親水性單體的重量比例通常是介於1:6至1:99之間。在本發明的某些具體實施例中,所述親水性單體的分子結構中優選是具有丙烯醯基(acryl group)官能基,並且在該些具體實施例中,所述輪烷分子與親水性單體的重量比例優選是介於1:6至1:94之間。It is also worth mentioning that, as mentioned above, the weight ratio of the rotaxane molecule to the hydrophilic monomer is usually between 1:6 and 1:99. In some specific embodiments of the present invention, the molecular structure of the hydrophilic monomer preferably has an acryl group functional group, and in these specific embodiments, the rotaxane molecule and the hydrophilic The weight ratio of the sexual monomer is preferably between 1:6 to 1:94.

其中,上述具有丙烯醯基(acryl group)的官能基可以例如是以下四種化學結構的至少其中之一。

Figure 02_image013
Figure 02_image015
Figure 02_image017
Figure 02_image019
Wherein, the functional group having an acryl group may be, for example, at least one of the following four chemical structures.
Figure 02_image013
Figure 02_image015
Figure 02_image017
Figure 02_image019

更進一步地說,本申請發明人發現,在不同環糊精的材料選擇下,所述輪烷分子與親水性單體的重量比例的優選範圍也有所不同。Furthermore, the inventors of the present application have discovered that the preferred range of the weight ratio of the rotaxane molecule to the hydrophilic monomer is also different under different selections of cyclodextrin materials.

舉例來說,當所述輪烷分子中的環狀分子為α-環糊精(α-cyclodextrin)或β-環糊精(β-cyclodextrin)時,所述輪烷分子與親水性單體的重量比例優選是介於1:11至1:54之間。當所述輪烷分子中的環狀分子為羥丙基-β-環糊精(hydroxypropyl-β-cyclodextrin)時,所述輪烷分子與親水性單體的重量比例優選是介於1:17至1:86之間。再者,當所述輪烷分子中的環狀分子為(2-羥丙基)-γ-環糊精((2-hydroxypropyl)-γ-cyclodextrin)時,所述輪烷分子與親水性單體的重量比例優選是介於1:19至1:94之間。For example, when the cyclic molecule in the rotaxane molecule is α-cyclodextrin (α-cyclodextrin) or β-cyclodextrin (β-cyclodextrin), the interaction between the rotaxane molecule and the hydrophilic monomer The weight ratio is preferably between 1:11 and 1:54. When the cyclic molecule in the rotaxane molecule is hydroxypropyl-β-cyclodextrin, the weight ratio of the rotaxane molecule to the hydrophilic monomer is preferably between 1:17 To 1:86. Furthermore, when the cyclic molecule in the rotaxane molecule is (2-hydroxypropyl)-γ-cyclodextrin ((2-hydroxypropyl)-γ-cyclodextrin), the rotaxane molecule and the hydrophilic monomer The weight ratio of the body is preferably between 1:19 to 1:94.

為了增加水膠鏡片的紫外光阻隔能力,在本發明的多個實施方式中,所述水膠組成物進一步包含一阻隔紫外光單體,並且所述阻隔紫外光單體為0.34重量份至1.68重量份。In order to increase the ultraviolet light blocking ability of the hydrogel lens, in various embodiments of the present invention, the hydrogel composition further includes an ultraviolet light blocking monomer, and the ultraviolet light blocking monomer is 0.34 parts by weight to 1.68 parts by weight. Parts by weight.

其中,所述阻隔紫外光單體是選自由一具有二苯基甲酮(benzophenone)的單體及一具有苯並三唑(benzotriazole)所組成的材料群組的至少其中之一。Wherein, the UV blocking monomer is at least one selected from the group consisting of a monomer with benzophenone and a material group with benzotriazole.

為了增加水膠組成物的溶解性,在本發明的多個實施方式中,所述水膠組成物進一步包含一助溶劑,並且所述助溶劑為4.33重量份至12.67重量份。In order to increase the solubility of the hydrogel composition, in various embodiments of the present invention, the hydrogel composition further includes a co-solvent, and the co-solvent is 4.33 parts by weight to 12.67 parts by weight.

其中,所述助溶劑是選自由甘油(glycerol)、2-丙醇(isopropyl alcohol)、正丁醇(n-butanol)、叔丁醇(t-butanol)、叔戊醇(t-amyl alcohol)及正己醇(n-hexanol)所組成的材料群組的至少其中之一。Wherein, the co-solvent is selected from glycerol, isopropyl alcohol, n-butanol, t-butanol, t-amyl alcohol And at least one of the material group consisting of n-hexanol.

為了使水膠鏡片具有特定顏色,在本發明的多個實施方式中,所述水膠組成物進一步包含一染料,且所述染料為0.002重量份至0.039重量份。In order to make the hydrogel lens have a specific color, in various embodiments of the present invention, the hydrogel composition further includes a dye, and the dye is 0.002 parts by weight to 0.039 parts by weight.

其中,所述染料是選自由活性藍19(disodium,1-amino-9,10-dioxo-4-[3-(2-sulfonatooxyethylsulfonyl)anilino]anthracene-2-sulfonate)、蘇丹三號(1-[4-(Phenylazo)phenylazo]-2-naphthol,Sudan III)、靛藍(2,2'-Bis(2,3-dihydro- 3-oxoindolylidene),Indigo)及喹啉黃(disodium 2-(1,3-dioxo- 2,3-dihydro-1H-inden-2-yl)quinolone-6,8-disulfonate,Quinoline yellow)所組成的材料群組的至少其中之一。Wherein, the dye is selected from reactive blue 19 (disodium,1-amino-9,10-dioxo-4-[3-(2-sulfonatooxyethylsulfonyl)anilino]anthracene-2-sulfonate), Sudan No. 3 (1-[ 4-(Phenylazo)phenylazo]-2-naphthol, Sudan III), indigo (2,2'-Bis(2,3-dihydro- 3-oxoindolylidene), Indigo) and quinoline yellow (disodium 2-(1,3) -dioxo- 2,3-dihydro-1H-inden-2-yl)quinolone-6,8-disulfonate, Quinoline yellow) at least one of the material group.

進一步地說,在本發明的一較佳實施例中,所述輪烷分子的直鏈狀分子(如:PEG、PVA、PPG)具有相對高的分子量,從而具有相對長的高分子鏈段。具體而言,所述輪烷分子中的直鏈狀分子具有介於2,000至20,000之間的平均分子量、優選介於4,000至15,000之間、且特優選介於4,000至8,000之間。根據上述配置,由於所述輪烷分子中的直鏈狀分子具有足夠長的高分子鏈段,因此所述環狀分子在直鏈狀分子上有足夠的空間可以滑動,以使得所述環狀分子不容易自直鏈狀分子上脫離。據此,所述輪烷分子可以不需要包含有用來阻擋環狀分子自直鏈狀分子兩端脫離的封基(slopper/capping)。換句話說,在所述輪烷分子中,所述直鏈狀分子的兩端可以不需要形成有封基,其仍然可以穩定維持輪烷分子的型態。Furthermore, in a preferred embodiment of the present invention, the linear molecules of the rotaxane molecule (eg, PEG, PVA, PPG) have a relatively high molecular weight, and thus have a relatively long polymer chain segment. Specifically, the linear molecules in the rotaxane molecule have an average molecular weight between 2,000 and 20,000, preferably between 4,000 and 15,000, and particularly preferably between 4,000 and 8,000. According to the above configuration, since the linear molecule in the rotaxane molecule has a sufficiently long polymer segment, the cyclic molecule has enough space on the linear molecule to slide, so that the cyclic molecule Molecules are not easily detached from linear molecules. Accordingly, the rotaxane molecule may not need to contain a slopper/capping group for preventing the cyclic molecule from detaching from both ends of the linear molecule. In other words, in the rotaxane molecule, the two ends of the linear molecule do not need to be formed with a blocking group, which can still stably maintain the shape of the rotaxane molecule.

更進一步地說,在所述輪烷分子中,所述環狀分子(如:環糊精)的外圍具有親水性官能基(如:羥基,-OH基),以使得所述環狀分子的外圍具有較高的親水性。再者,所述環狀分子的內側具有疏水性空穴結構,以使得所述環狀分子的內側具有較高的疏水性,並且所述疏水性空穴結構能用以提供脂溶性活性成分進入於其內,以提升活性成份的搭載效果。由於所述環狀分子的外圍具有親水性官能基,因此所述輪烷分子能通過環狀分子外圍的親水性官能基與水膠組成物中的親水性單體(如:NVP、HEMA…等)作用或結合,以使得所述輪烷分子能在水膠組成物中均勻地分散(基於極性分子與極性分子之間的交互作用)。Furthermore, in the rotaxane molecule, the outer periphery of the cyclic molecule (such as cyclodextrin) has a hydrophilic functional group (such as a hydroxyl group, -OH group), so that the The periphery has high hydrophilicity. Furthermore, the inner side of the cyclic molecule has a hydrophobic cavity structure, so that the inner side of the cyclic molecule has higher hydrophobicity, and the hydrophobic cavity structure can be used to provide fat-soluble active ingredients to enter In it, to enhance the carrying effect of active ingredients. Since the periphery of the cyclic molecule has a hydrophilic functional group, the rotaxane molecule can pass through the hydrophilic functional group on the periphery of the cyclic molecule and the hydrophilic monomer (such as: NVP, HEMA, etc.) in the hydrogel composition. ) To act or combine to enable the rotaxane molecules to be uniformly dispersed in the hydrogel composition (based on the interaction between polar molecules and polar molecules).

更進一步地說,如圖1所示,在所述水膠組成物100中,所述輪烷分子1的直鏈狀分子11是以繞曲的型態分散在親水性單體2中,並且所述輪烷分子1包含有以串接的方式穿設在直鏈狀分子11上的多個環狀分子12。More specifically, as shown in FIG. 1, in the hydrogel composition 100, the linear molecules 11 of the rotaxane molecule 1 are dispersed in the hydrophilic monomer 2 in a twisted form, and The rotaxane molecule 1 includes a plurality of cyclic molecules 12 threaded on a linear molecule 11 in a series connection.

值得一提的是,在所述水膠組成物100中,多個串接的環狀分子12與其相鄰的多個串接的環狀分子12能通過氫鍵的作用力彼此吸引、而以彼此堆疊的方式排列(如圖2所示)。It is worth mentioning that in the hydrogel composition 100, a plurality of cyclic molecules 12 connected in series and a plurality of adjacent cyclic molecules 12 in series can attract each other through the force of hydrogen bonds, and Arranged on top of each other (as shown in Figure 2).

另外,請繼續參閱圖1所示,在所述水膠組成物100中,部分的環狀分子12並非是穿設在直鏈狀分子11上,而是散落在直鏈狀分子11的外側,以獨立分子的方式存在,但本發明不受限於此。In addition, please continue to refer to FIG. 1, in the hydrogel composition 100, part of the cyclic molecules 12 are not pierced on the linear molecules 11, but scattered on the outside of the linear molecules 11. It exists as an independent molecule, but the present invention is not limited to this.

再者,如圖2所示,基於氫鍵的作用力,多個彼此串接的環狀分子12在直鏈狀分子11上是以頭對頭(heads to heads)及尾對尾(tails to tails)的方式排列。Furthermore, as shown in Figure 2, based on the force of the hydrogen bond, a plurality of cyclic molecules 12 connected in series on the linear molecule 11 are heads to heads and tails to tails. ).

另外,值得一提的是,所述水膠組成物100能通過輪烷分子1的添加具有相對優異的拉伸性能。具體來說,由所述水膠組成物100製作而成的水膠鏡片具有介於250%至380%之間的延伸率,更優選為介於320%至380%。In addition, it is worth mentioning that the hydrogel composition 100 can have relatively excellent tensile properties through the addition of the rotaxane molecule 1. Specifically, the hydrogel lens made from the hydrogel composition 100 has an elongation between 250% and 380%, and more preferably between 320% and 380%.

[水膠組成物的製備方式][Preparation method of water glue composition]

輪烷分子製備方式可以例如是,將環狀分子與直鏈狀分子依本篇所述實施例所記載的用量比例,添加至水中,並且混合攪拌數小時,至完全反應後,以得到一反應溶液;接著將反應溶液乾燥,以得到輪烷分子粉末。The method for preparing rotaxane molecules can be, for example, by adding cyclic molecules to linear molecules in the amount ratio described in the examples of this article, and mixing and stirring for several hours until the complete reaction is completed to obtain a reaction Solution; The reaction solution is then dried to obtain rotaxane molecular powder.

水膠組成物的製備方式可以例如是,將上述輪烷分子、交聯劑、及起始劑等材料,緩慢地加入親水性單體中,並且混合攪拌數小時,至完全反應後,以得到水膠組成物。也就是說,在此實施方式中,環狀分子及直鏈狀分子是在製備水膠組成物之前,即形成為輪烷分子。The preparation method of the hydrogel composition can be, for example, by slowly adding the above-mentioned rotaxane molecule, crosslinking agent, and starting agent to the hydrophilic monomer, and mixing and stirring for several hours until the complete reaction is completed to obtain Water glue composition. That is, in this embodiment, the cyclic molecules and linear molecules are formed into rotaxane molecules before the hydrogel composition is prepared.

另外,水膠組成物製備方式也可以例如是:將環狀分子、直鏈狀分子、交聯劑、起始劑等材料,緩慢地加入親水性單體中,並且混合攪拌數小時,至完全反應後,以得到水膠組成物。也就是說,在此實施方式中,環狀分子及直鏈狀分子是在製備水膠組成物的同時,形成為輪烷分子。In addition, the preparation method of the hydrogel composition can also be, for example, adding cyclic molecules, linear molecules, crosslinking agents, initiators and other materials slowly to the hydrophilic monomer, and mixing and stirring for several hours until complete After the reaction, the hydrogel composition is obtained. In other words, in this embodiment, the cyclic molecules and linear molecules are formed into rotaxane molecules while preparing the hydrogel composition.

[水膠鏡片的製備方式][Preparation method of water gel lens]

水膠鏡片的製備方式可以例如是:將上述水膠組成物注入用於製造水膠鏡片的模具,並且對水膠組成物進行固化成型製程,以形成水膠鏡片的乾片半成品。The preparation method of the hydrogel lens may be, for example, injecting the above-mentioned hydrogel composition into a mold for manufacturing the hydrogel lens, and performing a curing molding process on the hydrogel composition to form a semi-finished product of the dry film of the hydrogel lens.

接著,將水膠鏡片的乾片半成品浸泡於緩衝溶液中,直到水膠鏡片膨潤(水化製程)。然後,將緩衝溶液填充於包裝容器內,將水膠鏡片浸泡於緩衝溶液中,接著,進行密封及滅菌處理,如此即完成了隱形眼鏡產品的製作。Then, soak the dry semi-finished product of the hydrogel lens in a buffer solution until the hydrogel lens swells (hydration process). Then, the buffer solution is filled in the packaging container, the hydrogel lens is immersed in the buffer solution, and then sealed and sterilized, thus completing the production of the contact lens product.

其中,上述活性成分(如:小分子藥物、蛋白藥物或基因)可以例如是被添加或被摻入製作隱形眼鏡的材料之一;或者,也可以例如是在隱形眼鏡脫模及膨潤過程中,負載至隱形眼鏡上;或者,也可以是溶解在浸泡隱形眼鏡之緩衝溶液中,而負載至隱形眼鏡上。據此,當使用者將隱形眼鏡貼合在眼球表面時,上述活性成分即可隨時間緩慢地從鏡片中釋放出來,而被使用者的眼部所吸收。Among them, the above-mentioned active ingredients (such as small molecule drugs, protein drugs, or genes) can be added or incorporated into one of the materials used to make contact lenses; or, for example, can also be used in the mold release and swelling process of contact lenses. Load on the contact lens; or, it can also be dissolved in the buffer solution for immersing the contact lens and loaded on the contact lens. Accordingly, when the user attaches the contact lens to the surface of the eyeball, the above-mentioned active ingredients can be slowly released from the lens over time and be absorbed by the user's eye.

換句話說,上述活性成分(如:小分子藥物、蛋白藥物或基因)是如何添加或負載至輪烷分子中。在本發明的多個實施例中,上述活性成分可以例如是在鏡片原料配製時添加、在鏡片水化時添加、或在保存液中添加。In other words, how are the above active ingredients (such as small molecule drugs, protein drugs or genes) added or loaded into the rotaxane molecule? In various embodiments of the present invention, the above-mentioned active ingredient may be added during the preparation of the lens material, added during the hydration of the lens, or added in the preservation solution, for example.

在此緩釋系統下,隱形眼鏡可以負載的活性成分可以例如是具有清涼或止癢效果的成分,例如:薄荷醇(menthol、l-menthol)、樟腦(d-camphor、dl-camphor)、冰片(d-borneol)、氯化鉀(potassium chloride)。Under this sustained-release system, the active ingredients that the contact lens can load can be, for example, ingredients with cooling or anti-itch effects, such as menthol (menthol, l-menthol), camphor (d-camphor, dl-camphor), and borneol. (D-borneol), potassium chloride (potassium chloride).

所述活性成分也可以例如是具有抗發炎效果的成分,例如:鹽酸溶菌酶(lysozyme hydrochloride)、甘草酸鉀(dipotassium glycyrrhizinate)、6-氨基己酸(aminocaproic acid、ε-aminocaproic acid、6-aminohexanoic acid)、硫酸鋅(zinc sulfate)、維生素B2(vitamin B2、riboflavin)、氮磺酸鈉(sodium azulene sulfonic acid)、磺胺甲噁唑(sulfamethoxazole、sulfamethoxazole sodium)、普拉洛芬(prano-profen)。The active ingredient may also be, for example, an ingredient having an anti-inflammatory effect, such as: lysozyme hydrochloride, dipotassium glycyrrhizinate, 6-aminocaproic acid, ε-aminocaproic acid, 6-aminohexanoic acid, etc. acid), zinc sulfate, vitamin B2 (vitamin B2, riboflavin), sodium azulene sulfonic acid, sulfamethoxazole (sulfamethoxazole, sulfamethoxazole sodium), prano-profen (prano-profen) .

所述活性成分也可以例如是具有舒緩結膜充血症狀效果的成分,例如:萘甲唑啉(naphazoline、naphazoline hydrochloride)、四氫唑啉(tetrahydrozoline、tetryzoline、tetrahydrozoline hydrochloride)、三氯叔丁醇(chlorobutanol、chlorobutanol hemihydrate)、鹽酸麻黃鹼(phenylephrine hydrochloride)、苯腎上腺素(phenylephrine)。所述活性成分也可以例如是具有抗氧化或改善眼睛疲勞效果的成分,例如:維生素E(vitamin E、α-tocopheryl acetate)、L-天門冬氨酸鉀(L-potassium aspartate)、天門冬氨酸鎂(magnesium L-aspartate)、硫酸軟骨素(chondroitin sulfate、chondroitin sulfate sodium salt、sodium chondroitin chloride)、新斯明甲基硫酸鹽(neostigmine methylsulfate)、精胺酸(asparagine)、維他命B12(vitamin B12、cyanocobalamin、methylcobalamin、adenosylcobalamin、hydroxocobalamin)、維生素B5(vitamin B5、pantothenic acid)、維生素B6(vitamin B6、pyridoxine hydrochloride)、維他命A(vitamin A、vitamin A palmitate)、牛磺酸(taurine)。The active ingredient may also be, for example, an ingredient that has the effect of relieving the symptoms of conjunctival hyperemia, such as naphazoline (naphazoline, naphazoline hydrochloride), tetrahydrozoline (tetrahydrozoline, tetryzoline, tetrahydrozoline hydrochloride), and chlorobutanol (chlorobutanol). , Chlorobutanol hemihydrate, phenylephrine hydrochloride, phenylephrine. The active ingredient can also be, for example, an ingredient with anti-oxidation or eye fatigue effects, such as vitamin E (vitamin E, α-tocopheryl acetate), L-potassium aspartate, and aspartate. Magnesium (magnesium L-aspartate), chondroitin sulfate (chondroitin sulfate, chondroitin sulfate sodium salt, sodium chondroitin chloride), neostigmine methylsulfate (neostigmine methylsulfate), arginine (asparagine), vitamin B12 (vitamin B12) , Cyanocobalamin, methylcobalamin, adenosylcobalamin, hydroxocobalamin, vitamin B5 (vitamin B5, pantothenic acid), vitamin B6 (vitamin B6, pyridoxine hydrochloride), vitamin A (vitamin A, vitamin A palmitate), taurine (taurine).

所述活性成分也可以例如是具有抗敏或止癢效果的成分,例如:苯海拉明(diphenhydramine、diphenhydramine hydrochloride)、氯苯那敏(chlorpheniramine、chlorpheniramine maleate)、曲尼司特(tranilast)。The active ingredient may also be, for example, an ingredient having anti-allergic or anti-itch effects, such as diphenhydramine (diphenhydramine, diphenhydramine hydrochloride), chlorpheniramine (chlorpheniramine, chlorpheniramine maleate), and tranilast.

再者,所述活性成分也可以例如是具有保濕或舒敏等效果的成分,例如:硼酸(boric acid)、甘油(glycerine)、玻尿酸(hyaluronic acid)、多元醇(polyol)、尿囊素(allantoin)。Furthermore, the active ingredient may also be, for example, an ingredient with moisturizing or soothing effects, such as boric acid, glycerine, hyaluronic acid, polyol, allantoin ( allantoin).

[水膠鏡片][Water Gel Lens]

本發明實施例也提供一種水膠鏡片,所述水膠鏡片是由上述水膠組成物所形成。The embodiment of the present invention also provides a water gel lens, the water gel lens is formed by the above water gel composition.

其中,所述輪烷分子至少分佈於所述鏡片主體的一凹弧面或一凸弧面上,以形成一輪烷分子層,並且所述輪烷分子經配置負載一活性成分。其中,所述活性成分為小分子藥物、蛋白藥物及基因的至少其中之一。Wherein, the rotaxane molecules are distributed on at least a concave arc surface or a convex arc surface of the lens body to form a layer of rotaxane molecules, and the rotaxane molecules are configured to carry an active ingredient. Wherein, the active ingredient is at least one of small molecule drugs, protein drugs, and genes.

藉此,當使用者將隱形眼鏡貼合在眼球表面時,上述活性成分即可隨時間緩慢地從鏡片中釋放出來,而被使用者的眼部吸收。Thereby, when the user attaches the contact lens to the surface of the eyeball, the above-mentioned active ingredients can be slowly released from the lens over time and absorbed by the user's eye.

再者,所述鏡片主體的折射率(refractive index)優選介於1.315至1.598之間、且特優選介於1.398至1.485之間。Furthermore, the refractive index of the lens body is preferably between 1.315 and 1.598, and particularly preferably between 1.398 and 1.485.

所述鏡片主體的可見光穿透率(visible light transmittance)優選不小於90%、且特優選不小於95%。The visible light transmittance of the lens body is preferably not less than 90%, and particularly preferably not less than 95%.

所述鏡片主體的動態接觸角(dynamic contact angle,DCA)優選小於38、且特優選小於35,以具有良好的濕潤性。The dynamic contact angle (DCA) of the lens body is preferably less than 38, and particularly preferably less than 35, so as to have good wettability.

在本發明的多個實施方式中,所述隱形眼鏡的鏡片主體也可以例如是本技術領域中習知的任何鏡體。舉例來說,所述鏡片主體可以例如是硬性透氧性角膜接觸鏡(rigid gas permeable,RGP)、水凝膠軟式隱形眼鏡(hydrogel soft contact lens,SCL)或矽水膠軟式隱形眼鏡(silicone hydrogel soft contact lens)。In various embodiments of the present invention, the lens body of the contact lens may also be, for example, any lens body known in the technical field. For example, the lens body may be a rigid oxygen permeable contact lens (rigid gas permeable, RGP), a hydrogel soft contact lens (hydrogel soft contact lens, SCL), or a silicone hydrogel soft contact lens (silicone hydrogel). soft contact lens).

[實驗數據測試][Experimental data test]

以下,參照表一中的示範例1至4詳細說明本發明之內容。然而,以下示範例僅作為幫助了解本發明,本發明的範圍並不限於這些示範例。Hereinafter, the content of the present invention will be described in detail with reference to exemplary examples 1 to 4 in Table 1. However, the following examples are only used to help understand the present invention, and the scope of the present invention is not limited to these examples.

表一中示範例的鏡片是通過上文中的水膠組成物的製備方式及水膠鏡片的製備方式所獲得。The exemplary lenses in Table 1 are obtained by the above preparation method of the water gel composition and the preparation method of the water gel lens.

表一中示範例的鏡片在製備完成後,皆進行物化特性測試,諸如:基弧(base curve,BC)、中心厚度(center thickness,CT)、直徑(diameter,DIA)、折射率(refractive index)、光穿透率(light transmittance)、含水率(water content)、大氣脫水率(atmospheric dehydration)、潤滑性(lubricity)、動態接觸角(dynamic contact angle,DCA)、延伸率(elongation)、水萃取測試(water extraction test)及正己烷萃取測試(hexane extraction test)。After the lenses of the exemplary examples in Table 1 are prepared, they are tested for physical and chemical properties, such as: base curve (BC), center thickness (CT), diameter (diameter, DIA), and refractive index (refractive index). ), light transmittance, water content, atmospheric dehydration, lubricity, dynamic contact angle (DCA), elongation, water Water extraction test and hexane extraction test.

動態接觸角的量測,係使用動態接觸角量測儀,通過貼泡法(captive bubble method)作為量測接觸角的方法。貼泡法為經常用來量測隱形眼鏡的濕潤性或親水性的量測方法。一般而言,水膠隱形眼鏡的動態接觸角可小於50度。根據以下示範例1至4中所製作而成的水膠鏡片,其動態接觸角皆不大於80度,具體而言是皆不大於38度,且更具體而言是皆不大於35度,其具有良好的濕潤性。The dynamic contact angle is measured by using a dynamic contact angle measuring instrument, and the captive bubble method is used as the method to measure the contact angle. The bubble sticking method is a measurement method often used to measure the wettability or hydrophilicity of contact lenses. Generally speaking, the dynamic contact angle of water gel contact lenses can be less than 50 degrees. According to the following examples 1 to 4, the hydrogel lenses produced have dynamic contact angles of no more than 80 degrees, specifically, no more than 38 degrees, and more specifically, no more than 35 degrees. Has good wettability.

大氣脫水率的量測,係可以用來評估鏡片材質的保水程度的重要指標之一。量測方式為,將數片經水化膨潤後的水膠鏡片置於濕布上輕輕擦拭,以去除多餘的水份;將上述鏡片放入天秤上的樣品盤中,秤重紀錄鏡片的重量,並且記錄不同時間點(如:大氣脫水第10分鐘、大氣脫水第30分鐘、大氣脫水第60分鐘)的重量。表一顯示在不同的示範例中,鏡片大氣脫水率的量測結果。The measurement of atmospheric dehydration rate is one of the important indicators that can be used to evaluate the degree of water retention of lens materials. The measurement method is as follows: put several hydrated and swelled hydrogel lenses on a damp cloth and gently wipe to remove excess water; put the above lenses in the sample pan on the balance, weigh the record lens Weight, and record the weight at different time points (such as: the 10th minute of air dehydration, the 30th minute of air dehydration, the 60th minute of air dehydration). Table 1 shows the measurement results of the atmospheric dehydration rate of the lens in different examples.

據了解,隱形眼鏡過快乾燥是配戴者考慮要停止使用隱形眼鏡的主要原因之一。如下表一,本申請發明人意外發現,添加有輪烷分子的水膠鏡片(示範例1至4)與未添加有輪烷分子的水膠鏡片(比較例1)相比,添加有輪烷分子的水膠鏡片具有較低的脫水速率。也就是說,添加有輪烷分子的隱形眼鏡的乾燥速率相對較慢,配戴者較不容易感到鏡體乾燥。It is understood that the rapid drying of contact lenses is one of the main reasons for wearers to consider stopping using contact lenses. As shown in Table 1, the inventor of the present application unexpectedly discovered that the hydrogel lens with rotaxane molecules added (Exemplary Examples 1 to 4) is compared with the hydrocolloid lens without rotaxane molecules (Comparative Example 1). Molecular hydrogel lenses have a lower dehydration rate. In other words, the drying rate of contact lenses with added rotaxane molecules is relatively slow, and the wearer is less likely to feel the lens body dry.

延伸率的量測,係用來評估鏡片的拉伸彈性。更具體地說,量測方式是將經由水化膨潤後的鏡片,使用尺規量測以進行此實驗,其做法為將鏡片本體沿著其中心軸相對距離0.25公分的兩端固定(即鏡片本體的可見長度為0.5公分),並且鏡片的左側固定端對齊尺規的0公分處,以一固定力量將鏡片本體沿其中心軸的方向往鏡片本體的右側方向拉伸,紀錄鏡片本體於破裂前最後的長度(公分),然後將拉伸後的長度數值減去拉伸前的長度數值,再除以拉伸前的長度數值,以計算延伸率數值,以百分率表示之。The measurement of elongation is used to evaluate the tensile elasticity of the lens. More specifically, the measurement method is to use a ruler to measure the lens after hydration and swelling to carry out this experiment. The visible length of the body is 0.5 cm), and the left fixed end of the lens is aligned with the 0 cm of the ruler. With a fixed force, stretch the lens body along the direction of its central axis to the right side of the lens body to record the break of the lens body. The last length (cm) before the stretch, and then subtract the value of the length before stretching from the value of the stretched length, and then divide by the value of the length before stretching to calculate the elongation value, which is expressed as a percentage.

延伸率的計算公式為: 延伸率(%) = 拉伸後長度 - 拉伸前長度 x 100% 拉伸前長度 The calculation formula of elongation is: Elongation (%) = Length after stretching-Length before stretching x 100% Length before stretching

延伸率量測為評估鏡片性質的重要指標之一,當鏡片太硬時(如:延伸率小於150%),使用者在配戴時,鏡片容易使眼睛產生不舒適的感受。當鏡片太軟時(如:延伸率大於500%),使用者在準備要配戴鏡片而將鏡片放置於其指腹時,鏡片將難以平整地放置於指腹,而使得鏡片配戴不易。根據以下示範例1至4所製作而成的水膠鏡片具有介於250%至380%之間的延伸率,更具體而言為介於320%至380%之間。The measurement of elongation is one of the important indicators for evaluating the properties of lenses. When the lens is too hard (for example, the elongation is less than 150%), the lens will easily cause discomfort to the eyes when the user wears it. When the lens is too soft (for example, the elongation is greater than 500%), when the user prepares to wear the lens and places the lens on the finger pad, it will be difficult for the lens to be placed flat on the finger pad, making it difficult to wear the lens. The hydrogel lenses manufactured according to the following example 1 to 4 have an elongation between 250% and 380%, more specifically between 320% and 380%.

潤滑性的量測,為評估鏡片配戴舒適性的重要指標之一。具有良好潤滑性的隱形眼鏡鏡片,可提供使用者良好的佩戴舒適度。評估方式是採用盲測評分,評分為1分至10分,分數越高則潤滑度表現越好。根據以下示範例1至4所製作而成的水膠鏡片皆具有5分左右的評分結果。The measurement of lubricity is one of the important indicators for evaluating the wearing comfort of lenses. Contact lens lenses with good lubricity can provide users with good wearing comfort. The evaluation method is to use a blind test score, the score is 1 to 10 points, the higher the score, the better the lubricity performance. The hydrogel lenses produced according to the following example 1 to 4 all have a score of about 5 points.

含水量的量測,係指在平衡狀態下被鏡片本體吸收的水量。含水量訂定依據是參考ISO18369-4。含水量可藉由下列方式測定:取數片經水化膨潤後的鏡片,將該些鏡片置於濕布上輕輕擦拭以除去多餘的水份,將該些鏡片放入天秤上的樣品盤中,並且秤重紀錄脫水前的鏡片重量(a),將該些鏡片置入恆溫恆濕烘箱數小時後,秤重脫水後的鏡片重量(b),然後將脫水前的鏡片重量(a)減去脫水後的鏡片重量(b),再除以脫水前的鏡片重量(a),計算所得之值即為此鏡片本體的含水量。含水量可以被表示為百分率。根據以下示範例1至4所製作而成的水膠鏡片皆具有介於10%至75%(w/w)的含水率,具體為32%至70%,更具體為介於36%至65%之間。The measurement of water content refers to the amount of water absorbed by the lens body under equilibrium. The water content is determined according to ISO18369-4. The water content can be measured by the following method: Take a few lenses that have been hydrated and swelled, place the lenses on a damp cloth and gently wipe to remove excess water, and place the lenses in the sample pan on the balance. Weigh and record the weight of the lens before dehydration (a), put the lenses in a constant temperature and humidity oven for several hours, weigh the weight of the dehydrated lens (b), and then weigh the lens before dehydration (a) Subtract the weight of the lens after dehydration (b), and divide it by the weight of the lens before dehydration (a), and the calculated value is the water content of the lens body. The water content can be expressed as a percentage. The hydrogel lenses made according to the following example 1 to 4 all have a moisture content of 10% to 75% (w/w), specifically 32% to 70%, more specifically 36% to 65 %between.

含水量的計算公式為: 含水量(%) = 鏡體濕重(a)- 鏡體乾重(b) x 100% 鏡體濕重(a) The calculation formula of water content is: Water content (%) = Lens body wet weight (a)-Lens body dry weight (b) x 100% Lens body wet weight (a)

另外需說明的是,在以下表一中,鏡片的基弧(BC)及直徑(DIA)是由隱形眼鏡光學量測儀量測獲得。鏡片的中心厚度(CT)是通過鏡片厚度檢測儀量測獲得。鏡片的折射率是使用阿貝折射儀(Abbe refractiometer)量測獲得。鏡片的光穿透率是使用紫外線分光光譜儀量測可見光穿透值獲得。In addition, it should be noted that in the following table 1, the base curve (BC) and diameter (DIA) of the lens are measured by a contact lens optical measuring instrument. The central thickness (CT) of the lens is measured by a lens thickness detector. The refractive index of the lens is measured by an Abbe refractiometer. The light transmittance of the lens is obtained by measuring the visible light transmittance value using an ultraviolet spectrometer.

[比較例1及示範例1至4][Comparative Example 1 and Exemplary Examples 1 to 4]

以下表一列出示比較例1(控制組)及示範例1至4的水膠組成物,及其物化特性測試結果。上述示範例僅為示例,並非用以限制本發明。The following Table 1 lists the water gel compositions of Comparative Example 1 (control group) and Exemplary Examples 1 to 4, and the test results of their physical and chemical properties. The above exemplary examples are only examples, and are not intended to limit the present invention.

具體而言,比較例1及示範例1至4的水膠組成物,皆包含:85.28重量份的親水性單體、0.88重量份的交聯劑、0.50重量份的起始劑、1.11重量份的阻隔紫外光單體、12.21重量份的助溶劑以及0.02重量份的染料。其中,比較例1為控制組,其未添加有輪烷分子,而示範例1至示範例4則添加有不同重量份的輪烷分子。其中,在示範例1至4的輪烷分子中,環狀分子是採用環糊精(cyclodextrin),並且線性分子是採用聚乙二醇(PEG)。Specifically, the hydrogel compositions of Comparative Example 1 and Exemplary Examples 1 to 4 all include: 85.28 parts by weight of hydrophilic monomer, 0.88 parts by weight of crosslinking agent, 0.50 parts by weight of initiator, and 1.11 parts by weight The UV blocking monomer, 12.21 parts by weight of co-solvent and 0.02 parts by weight of dye. Among them, Comparative Example 1 is the control group, which did not add rotaxane molecules, while Exemplary Example 1 to Exemplary Example 4 added different weight parts of rotaxane molecules. Among them, among the rotaxane molecules of Exemplary Examples 1 to 4, cyclodextrin is used as the cyclic molecule, and polyethylene glycol (PEG) is used as the linear molecule.

[表1]   比較例1 (控制組) 示範例1 示範例2 示範例3 示範例4 輪烷分子 (重量份) 0 4.00 5.10 6.90 1.35 環狀分子: 線性分子 (重量比例) 0 20.5:1 11.9:1 8.80:1 30.6:1 基弧 (mm) 8.425 8.450 8.425 8.500 8.475 中心厚度 (mm) 0.082 0.078 0.090 0.086 0.085 直徑 (mm) 14.15 14.15 14.10 14.05 14.15 折射率 1.4044 1.4054 1.4051 1.4044 1.4049 穿透率 (%) 98.707 99.027 98.797 98.931 99.125 含水量 (%) 57.21 56.82 57.23 56.82 57.10 動態接觸角(度) 30.45 26.49 25.95 29.33 25.66 延伸率 (%) 320 340 320 330 350 大氣脫水 第10分鐘 (%) 12.40 10.88 10.95 10.85 10.78 大氣脫水 第30分鐘 (%) 34.04 30.35 31.25 32.20 30.65 大氣脫水 第60分鐘 (%) 52.21 50.09 50.55 50.75 51.52 潤滑性 (1~10分) 5.0 5.0 4.9 5.1 5.0 水萃取 (%) 0.21 0.11 0.08 0.75 0.10 正己烷萃取(%) 0.09 0.12 0.09 0.09 0.11 [Table 1] Comparative example 1 (control group) Example 1 Example 2 Example 3 Example 4 Rotaxane molecule (parts by weight) 0 4.00 5.10 6.90 1.35 Cyclic molecule: Linear molecule (weight ratio) 0 20.5:1 11.9:1 8.80:1 30.6:1 Base arc (mm) 8.425 8.450 8.425 8.500 8.475 Center thickness (mm) 0.082 0.078 0.090 0.086 0.085 Diameter (mm) 14.15 14.15 14.10 14.05 14.15 Refractive index 1.4044 1.4054 1.4051 1.4044 1.4049 Penetration rate (%) 98.707 99.027 98.797 98.931 99.125 Water content (%) 57.21 56.82 57.23 56.82 57.10 Dynamic contact angle (degrees) 30.45 26.49 25.95 29.33 25.66 Elongation (%) 320 340 320 330 350 10 minutes of atmospheric dehydration (%) 12.40 10.88 10.95 10.85 10.78 30 minutes of atmospheric dehydration (%) 34.04 30.35 31.25 32.20 30.65 60 minutes of atmospheric dehydration (%) 52.21 50.09 50.55 50.75 51.52 Lubricity (1-10 points) 5.0 5.0 4.9 5.1 5.0 Water extraction (%) 0.21 0.11 0.08 0.75 0.10 Hexane extraction (%) 0.09 0.12 0.09 0.09 0.11

由表1可得知,添加有輪烷分子的水膠鏡片(示範例1至示範例4)相較於未添加輪烷分子的水膠鏡片(比較例1,控制組),添加有輪烷分子的水膠鏡片具有較低的動態接觸角。也就是說,添加有輪烷分子的隱形眼鏡的具有較佳的濕潤性。It can be seen from Table 1 that the hydrogel lens with rotaxane molecules added (Example 1 to Example 4) is compared with the hydrogel lens without rotaxane molecule (Comparative Example 1, control group), with rotaxane added The molecular hydrogel lens has a low dynamic contact angle. In other words, contact lenses with rotaxane molecules have better wettability.

由表1可得知,添加有輪烷分子的水膠鏡片(示範例1至示範例4)相較於未添加輪烷分子的水膠鏡片(比較例1,控制組),添加有輪烷分子的水膠鏡片具有較低的大氣脫水速率。也就是說,添加有輪烷分子的隱形眼鏡的乾燥速率相對較慢,因此配戴者較不容易感到鏡體乾燥。It can be seen from Table 1 that the hydrogel lens with rotaxane molecules added (Example 1 to Example 4) is compared with the hydrogel lens without rotaxane molecule (Comparative Example 1, control group), with rotaxane added Molecular hydrogel lenses have a lower atmospheric dehydration rate. In other words, the drying rate of contact lenses added with rotaxane molecules is relatively slow, so the wearer is less likely to feel the lens body dry.

由表1可以得知,添加有輪烷分子的水膠鏡片(示範例1至示範例4)在隱形眼鏡的基本物化特性表面上(如:基弧、中心厚度、直徑、折射率、延伸率、穿透率、潤滑性)皆不亞於未添加輪烷分子的水膠鏡片(比較例1,控制組)。也就是說,水膠鏡片在導入輪烷分子的情況下,不僅具有較佳的濕潤性、較低的大氣脫水速率、負載及緩釋活性成分的潛力,並且其仍然能夠維持隱形眼鏡鏡片所需的特性。It can be seen from Table 1 that the hydrocolloid lenses added with rotaxane molecules (Example 1 to Example 4) are on the surface of the basic physical and chemical properties of the contact lens (such as: base curve, center thickness, diameter, refractive index, elongation , Penetration, lubricity) are no less than the hydrogel lens without adding rotaxane molecules (Comparative Example 1, control group). That is to say, when the rotaxane molecule is introduced into the hydrocolloid lens, it not only has better wettability, lower atmospheric dehydration rate, potential for loading and slow release of active ingredients, but also it can still maintain the requirements of contact lens lenses. Characteristics.

再者,表1中的水膠鏡片的水萃取物重量以及正己烷萃取物重量皆非常低,其顯示水膠組成物的固化相當完全。Furthermore, the weight of the water extract and the weight of the n-hexane extract of the hydrogel lenses in Table 1 are very low, which shows that the curing of the hydrogel composition is quite complete.

[隱形眼鏡配戴狀況臨床評估][Clinical Evaluation of Contact Lens Wearing Condition]

以下為兩項在實務操作上常用的隱形眼鏡配戴狀況臨床評估方法,其包含問卷訪問及淚河高度。The following are two commonly used clinical assessment methods for contact lens wearing conditions in practical operations, including questionnaire interviews and the height of tears.

問卷訪問(主觀測試):利用隱形眼鏡調查問卷,詢問配戴症狀、發生頻率,以及配戴長時間的感受來了解配戴者的實際狀況。Questionnaire interview (subjective test): Use the contact lens questionnaire to ask about the symptoms of wearing, the frequency of occurrence, and the feeling of wearing for a long time to understand the actual condition of the wearer.

問卷訪問的評估方法,是將表1中的比較例1及示範例1至4所製作成的水膠鏡片,皆泡入包含有薄荷醇的隱形眼鏡保存溶液中,以進行薄荷醇分子的搭載,然後再取出這些隱形眼鏡。接著,挑選5位受試者,進行綜合評價測試,所述測試經由5位年齡介於25歲至40歲的受試者所完成,並且,5位受試者皆在不知道所配戴之鏡片組例及不知道藥物添加成分的情況下進行試驗,評分為1分至10分,分數越高感受即表示該測試項目感受越強烈,5位受試者綜合結果顯示於表2中。The evaluation method of the questionnaire interview is to immerse the hydrogel lenses made in Comparative Example 1 and Exemplary Examples 1 to 4 in Table 1 in a contact lens preservation solution containing menthol to carry the menthol molecule. , And then take out these contact lenses. Next, select 5 subjects to perform a comprehensive evaluation test. The test was completed by 5 subjects aged 25 to 40 years old, and all 5 subjects did not know what they were wearing. The test was conducted in the case of the lens group and without knowing the added ingredients of the drug, and the score was 1 to 10 points. The higher the score, the stronger the feeling of the test item. The comprehensive results of the 5 subjects are shown in Table 2.

[表2] 評價項目 時間點 比較例1 示範例1至4 涼感 剛戴上時 6 6.2至6.5 戴上30分鐘後 2.8 3.8至4.4 戴上1小時後 1.2 2.0至2.5 戴上2小時後 0.6 1.1至1.7 乾澀感 剛戴上時 2.2 1.8至2.0 戴上4小時後 3.2 2.0至2.2 眼睛異物感 剛戴上時 1.8 1.5至1.7 戴上4小時後 3.4 1.7至2.0 [Table 2] Evaluation item Point in time Comparative example 1 Example 1 to 4 Cool feeling When I first put it on 6 6.2 to 6.5 30 minutes after wearing 2.8 3.8 to 4.4 1 hour after wearing 1.2 2.0 to 2.5 2 hours after wearing 0.6 1.1 to 1.7 Dryness When I first put it on 2.2 1.8 to 2.0 4 hours after wearing 3.2 2.0 to 2.2 Foreign body sensation in eyes When I first put it on 1.8 1.5 to 1.7 4 hours after wearing 3.4 1.7 to 2.0

淚河高度(Tear Meniscus Height):使用角膜地形圖儀觀察,藉由觀察淚液層測量淚河高度,來判定受試者淚液是否充足。正常人淚河高度約為0.25 mm,若是測量高度低於此數值,代表已有淚水分泌不足之問題。Tear Meniscus Height: Observe with a corneal topography device and measure the height of the tear river by observing the tear layer to determine whether the subject’s tears are sufficient. The height of a normal person's tear channel is about 0.25 mm. If the measured height is lower than this value, it means that there is insufficient tear secretion.

淚河高度的評估方法,是將表1中的比較例1及示範例1至4所製作成的水膠鏡片,皆泡入包含有薄荷醇的隱形眼鏡保存溶液中,以進行薄荷醇分子的搭載,然後再取出這些隱形眼鏡。接著,挑選5位受試者,藉由量測淚河高度,來判定受試者淚液分泌量。當薄荷醇持續作用時,會刺激淚液分泌。所述測試經由5位年齡介於25歲至40歲的受試者所完成,並且,5位受試者皆在不知道所配戴之鏡片組例及不知道藥物添加成分的情況下進行試驗,5位受試者綜合結果顯示於表3中。The method for evaluating the height of the tear river is to immerse the hydrogel lenses made in Comparative Example 1 and Exemplary Examples 1 to 4 in Table 1 in a contact lens preservation solution containing menthol to perform menthol molecular analysis. Carry on, and then take out these contact lenses. Next, select 5 subjects, and determine the amount of tear secretion of the subjects by measuring the height of the tear river. When menthol continues to work, it will stimulate tear secretion. The test was completed by 5 subjects aged between 25 and 40 years old, and all 5 subjects did the test without knowing the lens set and the added ingredients of the drug. The combined results of 5 subjects are shown in Table 3.

[表3] 評價項目 時間點 比較例1 示範例1至4 淚河高度(mm) 剛戴上時 0.300 0.310至0.325 戴上2小時 0.240 0.282至0.298 戴上4小時後 0.230 0.265至0.272 [table 3] Evaluation item Point in time Comparative example 1 Example 1 to 4 Tear River Height (mm) When I first put it on 0.300 0.310 to 0.325 Wear it for 2 hours 0.240 0.282 to 0.298 4 hours after wearing 0.230 0.265 to 0.272

[實施例的有益效果][Beneficial effects of the embodiment]

本發明的其中一有益效果在於,本發明所提供的用於製備水膠鏡片的水膠組成物及水膠鏡片,其能通過在水膠組成物中導入輪烷分子(rotaxane)的技術方案,以使得最終形成的水膠鏡片能具有負載及緩釋活性成分的效果。One of the beneficial effects of the present invention is that the water gel composition and the water gel lens for preparing the water gel lens provided by the present invention can adopt the technical solution of introducing rotaxane molecules into the water gel composition, So that the final formed hydrocolloid lens can have the effect of loading and slow-release of active ingredients.

值得一提的是,本發明的水膠鏡片在導入輪烷分子的情況下,不僅具有負載及緩釋活性成分的效果,並且仍然能夠維持隱形眼鏡鏡片所需的特性,如:鏡片基弧(base curve,BC)、鏡片中心厚度(center thickness,CT)、鏡片直徑(diameter,DIA)、折射率、可見光穿透率或動態接觸角…等)。It is worth mentioning that when the rotaxane molecule is introduced, the hydrocolloid lens of the present invention not only has the effect of loading and slow-release of the active ingredient, but also can maintain the required characteristics of the contact lens, such as the lens base curve ( base curve, BC), lens center thickness (CT), lens diameter (diameter, DIA), refractive index, visible light transmittance or dynamic contact angle... etc.).

以上所公開的內容僅為本發明的優選可行實施例,並非因此侷限本發明的申請專利範圍,所以凡是運用本發明說明書及圖式內容所做的等效技術變化,均包含於本發明的申請專利範圍內。The content disclosed above is only the preferred and feasible embodiments of the present invention, and does not limit the scope of the patent application of the present invention. Therefore, all equivalent technical changes made using the description and schematic content of the present invention are included in the application of the present invention. Within the scope of the patent.

100:水膠組成物 1:輪烷分子 11:直鏈狀分子 12:環狀分子 2:親水性單體 100: Water glue composition 1: Rotaxane molecule 11: Linear molecule 12: cyclic molecule 2: Hydrophilic monomer

圖1為本發明實施例的輪烷分子分散於水膠組成物中的示意圖。Fig. 1 is a schematic diagram of a rotaxane molecule dispersed in a hydrogel composition according to an embodiment of the present invention.

圖2為本發明實施例的環狀分子彼此堆疊排列的示意圖。FIG. 2 is a schematic diagram of cyclic molecules stacked on each other according to an embodiment of the present invention.

100:水膠組成物 1:輪烷分子 11:直鏈狀分子 12:環狀分子 2:親水性單體 100: Water glue composition 1: Rotaxane molecule 11: Linear molecule 12: cyclic molecule 2: Hydrophilic monomer

Claims (38)

一種水膠組成物,其包括:一親水性單體,為60重量份至99.85重量份;一交聯劑,為0.01重量份至1重量份;一起始劑,為0.01重量份至2重量份;以及一輪烷分子(rotaxane),為0.1重量份至15重量份;其中,所述輪烷分子包含有至少一環狀分子及以穿串狀貫通至少一所述環狀分子的至少一直鏈狀分子;其中,在所述輪烷分子中,所述直鏈狀分子的平均分子量是介於2,000至20,000之間,並且所述輪烷分子未包含任何用來阻擋所述環狀分子自所述直鏈狀分子的兩端脫離的封基(slopper/capping)。 A hydrogel composition comprising: a hydrophilic monomer of 60 parts by weight to 99.85 parts by weight; a crosslinking agent of 0.01 parts by weight to 1 part by weight; and an initiator of 0.01 parts by weight to 2 parts by weight And a rotaxane molecule (rotaxane), which is 0.1 parts by weight to 15 parts by weight; wherein the rotaxane molecule includes at least one cyclic molecule and at least a linear chain penetrating through at least one of the cyclic molecules in a string Molecule; wherein, in the rotaxane molecule, the average molecular weight of the linear molecule is between 2,000 to 20,000, and the rotaxane molecule does not contain any used to block the cyclic molecule from the A slopper/capping group in which both ends of a linear molecule are separated. 如請求項1所述的水膠組成物,其中,所述輪烷分子為0.1重量份至12重量份。 The water gel composition according to claim 1, wherein the rotaxane molecule is 0.1 to 12 parts by weight. 如請求項2所述的水膠組成物,其中,所述輪烷分子為0.5重量份至8重量份。 The water gel composition according to claim 2, wherein the rotaxane molecule is 0.5 to 8 parts by weight. 如請求項1所述的水膠組成物,其中,在所述輪烷分子中,至少一所述環狀分子與至少一所述直鏈狀分子的所述重量比例介於1:1至50:1之間。 The hydrogel composition according to claim 1, wherein, in the rotaxane molecule, the weight ratio of at least one cyclic molecule to at least one linear molecule is between 1:1 and 50 : Between 1. 如請求項4所述的水膠組成物,其中,在所述輪烷分子中,至少一所述環狀分子與至少一所述直鏈狀分子的所述重量比例介於5:1至35:1之間。 The hydrogel composition according to claim 4, wherein, in the rotaxane molecule, the weight ratio of at least one cyclic molecule to at least one linear molecule is between 5:1 and 35 : Between 1. 如請求項1所述的水膠組成物,其中,至少一所述環狀分子為環糊精(cyclodextrin)或其衍生物。 The hydrogel composition according to claim 1, wherein at least one of the cyclic molecules is cyclodextrin or a derivative thereof. 如請求項6所述的水膠組成物,其中,所述環糊精是選自由α-環糊精(α-cyclodextrin)、β-環糊精(β-cyclodextrin)、γ-環糊精(γ-cyclodextrin)、羥丙基-β-環糊精 (hydroxypropyl-β-cyclodextrin)、(2-羥丙基)-γ-環糊精((2-hydroxypropyl)-γ-cyclodextrin)、磺丁基醚-β-環糊精(sulfobutylether-β-cyclodextrin)及甲基-β-環糊精(methyl-β-cyclodextrin)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 6, wherein the cyclodextrin is selected from the group consisting of α-cyclodextrin (α-cyclodextrin), β-cyclodextrin (β-cyclodextrin), and γ-cyclodextrin ( γ-cyclodextrin), hydroxypropyl-β-cyclodextrin (hydroxypropyl-β-cyclodextrin), (2-hydroxypropyl)-γ-cyclodextrin ((2-hydroxypropyl)-γ-cyclodextrin), sulfobutylether-β-cyclodextrin (sulfobutylether-β-cyclodextrin) And at least one of the material group consisting of methyl-β-cyclodextrin (methyl-β-cyclodextrin). 如請求項1所述的水膠組成物,其中,至少一所述環狀分子為冠醚(crown ether)或其衍生物。 The hydrogel composition according to claim 1, wherein at least one of the cyclic molecules is crown ether or a derivative thereof. 如請求項8所述的水膠組成物,其中,所述冠醚是選自由12-冠-4(12-crown-4)、15-冠-5(15-crown-5)、18-冠-6(18-crown-6)、苯並-18-冠-6(benzo-18-crown-6)、苯並15-冠-5(benzo-15-crown-5)、二環己基-18-冠-6(dicyclohexyl-18-crown-6)、2-(羥甲基)-12-冠-4-醚(2-(hydroxymethyl)-12-crown-4-ether)、2-(羥甲基)-15-冠-5-醚(2-(hydroxymethyl)-15-crown-5-ether)及2-(羥甲基)-18-冠-6-醚(2-(hydroxymethyl)-18-crown-6-ether)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 8, wherein the crown ether is selected from 12-crown-4 (12-crown-4), 15-crown-5 (15-crown-5), 18-crown -6 (18-crown-6), benzo-18-crown-6 (benzo-18-crown-6), benzo-15-crown-5 (benzo-15-crown-5), dicyclohexyl-18 -Crown-6 (dicyclohexyl-18-crown-6), 2-(hydroxymethyl)-12-crown-4-ether (2-(hydroxymethyl)-12-crown-4-ether), 2-(hydroxymethyl)-12-crown-4-ether Base)-15-crown-5-ether (2-(hydroxymethyl)-15-crown-5-ether) and 2-(hydroxymethyl)-18-crown-6-ether (2-(hydroxymethyl)-18- crown-6-ether) at least one of the material groups. 如請求項1所述的水膠組成物,其中,至少一所述直鏈狀分子是選自由聚乙二醇(polyethylene glycol,PEG)、聚乙烯醇(polyvinyl alcohol,PVA)及聚丙二醇(polypropylene glycol,PPG)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 1, wherein at least one of the linear molecules is selected from polyethylene glycol (PEG), polyvinyl alcohol (PVA) and polypropylene glycol (polypropylene glycol). At least one of the material group consisting of glycol, PPG). 如請求項10所述的水膠組成物,其中,聚乙二醇具有如式(1)之結構:
Figure 109141266-A0305-02-0028-1
聚乙烯醇具有如式(2)之結構:
Figure 109141266-A0305-02-0029-2
聚丙二醇具有如式(3)之結構:
Figure 109141266-A0305-02-0029-3
其中,n為大於4的正整數。
The water glue composition according to claim 10, wherein the polyethylene glycol has a structure as shown in formula (1):
Figure 109141266-A0305-02-0028-1
Polyvinyl alcohol has a structure like formula (2):
Figure 109141266-A0305-02-0029-2
Polypropylene glycol has a structure like formula (3):
Figure 109141266-A0305-02-0029-3
Among them, n is a positive integer greater than 4.
如請求項11所述的水膠組成物,其中,所述直鏈狀分子的平均分子量介於200至20,000之間。 The water gel composition according to claim 11, wherein the average molecular weight of the linear molecule is between 200 and 20,000. 如請求項1所述的水膠組成物,其中,所述親水性單體為68.88重量份至99.85重量份。 The water gel composition according to claim 1, wherein the hydrophilic monomer is 68.88 parts by weight to 99.85 parts by weight. 如請求項1所述的水膠組成物,其中,所述親水性單體是選自由N-乙烯基吡咯烷酮(N-vinyl pyrrolidone,NVP)、2-羥基乙基甲基丙烯酸酯(2-hydroxyethyl methacrylate,HEMA)、甲基丙烯酸(methacrylic acid,MAA)、甲基丙烯酸甲酯(methyl methacrylate,MMA)、丙烯酸(acrylic acid,AAc)、N,N-二甲基丙烯醯胺(N,N-dimethyl acrylamide,DMA)、2-甲基-2-丙烯酸-2,3-二羥基丙酯(2,3-dihydroxypropyl methacrylate,GMMA)、N,N-二甲基甲基丙烯醯胺(N,N-dimethyl methacrylamide)及N-乙基-N-甲基乙醯胺(N-vinyl-N-methyl acetamide)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 1, wherein the hydrophilic monomer is selected from N-vinyl pyrrolidone (NVP), 2-hydroxyethyl methacrylate (2-hydroxyethyl methacrylate) methacrylate (HEMA), methacrylic acid (MAA), methyl methacrylate (MMA), acrylic acid (AAc), N,N-dimethylacrylamide (N,N- dimethyl acrylamide, DMA), 2,3-dihydroxypropyl methacrylate (GMMA), N,N-dimethyl acrylamide (N,N -dimethyl methacrylamide) and at least one of the material group consisting of N-vinyl-N-methyl acetamide (N-vinyl-N-methyl acetamide). 如請求項1所述的水膠組成物,其中,所述親水性單體具有乙烯基、乙醯基、丙烯基或丙烯醯基。 The water gel composition according to claim 1, wherein the hydrophilic monomer has a vinyl group, an acetyl group, an acrylic group or an acrylic group. 如請求項1所述的水膠組成物,其中,所述交聯劑為0.04重量份至0.57重量份。 The water gel composition according to claim 1, wherein the crosslinking agent is 0.04 parts by weight to 0.57 parts by weight. 如請求項1所述的水膠組成物,其中,所述交聯劑是選自由乙烯基乙二醇基二甲基丙烯酸酯(ethylene glycol dimethacrylate)、二乙烯基乙二醇基二甲基丙烯酸酯(diethylene glycol dimethacrylate)、三乙烯基乙二醇基二甲基丙烯酸酯(triethylene glycol dimethacrylate)、四乙烯基乙二醇基二甲基丙烯酸酯(tetraethylene glycol dimethacrylate)、烯丙基甲基丙烯酸酯(allyl methacrylate)、三乙烯基乙二醇基二烯丙基醚(triethylene glycol dially ether)、四乙烯基乙二醇基二烯丙基醚(tetraethylene glycol dially ether)及三羥甲基丙烷三甲基丙烯酸酯(1,1,1-trimethylolpropane trimethacrylate)所組成的材料群組的至少其中之一。 The water glue composition according to claim 1, wherein the crosslinking agent is selected from the group consisting of ethylene glycol dimethacrylate (ethylene glycol dimethacrylate). dimethacrylate), diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetravinyl glycol dimethacrylate Ester (tetraethylene glycol dimethacrylate), allyl methacrylate, triethylene glycol dially ether, tetraethylene glycol dially ether At least one of the material group consisting of tetraethylene glycol dially ether and 1,1,1-trimethylolpropane trimethacrylate. 如請求項1所述的水膠組成物,其中,所述起始劑為光起始劑,並且所述光起始劑為0.05重量份至0.72重量份。 The hydrogel composition according to claim 1, wherein the initiator is a photoinitiator, and the photoinitiator is 0.05 to 0.72 parts by weight. 如請求項18所述的水膠組成物,其中,所述光起始劑是選自由雙(1-(2,4-二氟苯基)-3-吡咯基)二茂鈦(bis(2,6-difluoro-3-(1-hydropyrro-1-yl)-phenyl)titanocene)、苯基雙(2,4,6-三甲基苯甲酰基)氧化膦(phenylbis-(2,4,6-trimethylbenzoyl)-phosphine oxide)及2-羥基-2-甲基-1-苯基-1-丙酮(2-hydroxy-2-methyl-1-phenyl-1-porpanone)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 18, wherein the photoinitiator is selected from the group consisting of bis(1-(2,4-difluorophenyl)-3-pyrrolyl) titanocene (bis(2 ,6-difluoro-3-(1-hydropyrro-1-yl)-phenyl)titanocene), phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide (phenylbis-(2,4,6 -trimethylbenzoyl)-phosphine oxide) and 2-hydroxy-2-methyl-1-phenyl-1-porpanone (2-hydroxy-2-methyl-1-phenyl-1-porpanone) at least one of them. 如請求項1所述的水膠組成物,其進一步包括:一阻隔紫外光單體,並且所述阻隔紫外光單體為0.34重量份至1.68重量份。 The water gel composition according to claim 1, which further comprises: an ultraviolet light blocking monomer, and the ultraviolet light blocking monomer is 0.34 parts by weight to 1.68 parts by weight. 如請求項20所述的水膠組成物,其中,所述阻隔紫外光單體是選自由一具有二苯基甲酮(benzophenone)的單體及一具有苯並三唑(benzotriazole)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 20, wherein the ultraviolet light blocking monomer is selected from the group consisting of a monomer having benzophenone and a monomer having benzotriazole At least one of the material groups. 如請求項1所述的水膠組成物,其進一步包括:一助溶劑,並且所述助溶劑為4.33重量份至12.67重量份。 The water glue composition according to claim 1, further comprising: a co-solvent, and the co-solvent is 4.33 parts by weight to 12.67 parts by weight. 如請求項22所述的水膠組成物,其中,所述助溶劑是選自由甘油(glycerol)、2-丙醇(isopropyl alcohol)、正丁醇(n-butanol)、叔丁醇(t-butanol)、叔戊醇(t-amyl alcohol)及正己醇(n-hexanol)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 22, wherein the co-solvent is selected from the group consisting of glycerol, isopropyl alcohol, n-butanol, and t-butanol (t-butanol). butanol), t-amyl alcohol (t-amyl alcohol) and n-hexanol (n-hexanol) composed of at least one of the material group. 如請求項1所述的水膠組成物,其進一步包括:一染料,並且所述染料為0.002重量份至0.039重量份。 The water gel composition according to claim 1, further comprising: a dye, and the dye is 0.002 parts by weight to 0.039 parts by weight. 如請求項24所述的水膠組成物,其中,所述染料是選自由活性藍19(disodium,1-amino-9,10-dioxo-4-[3-(2-sulfonatooxyethyl sulfonyl)anilino]anthracene-2-sulfonate)、蘇丹三號(1-[4-(Phenylazo)phenylazo]-2-naphthol,Sudan III)、靛藍(2,2'-Bis(2,3-dihydro-3-oxoindolylidene),Indigo)及喹啉黃(disodium 2-(1,3-dioxo-2,3-dihydro-1H-inden-2-yl)quinolone-6,8-disulfonate,Quinoline yellow)所組成的材料群組的至少其中之一。 The hydrogel composition according to claim 24, wherein the dye is selected from the group consisting of reactive blue 19 (disodium,1-amino-9,10-dioxo-4-[3-(2-sulfonatooxyethyl sulfonyl)anilino]anthracene -2-sulfonate), Sudan III (1-[4-(Phenylazo)phenylazo]-2-naphthol, Sudan III), indigo (2,2'-Bis(2,3-dihydro-3-oxoindolylidene), Indigo ) And quinoline yellow (disodium 2-(1,3-dioxo-2,3-dihydro-1H-inden-2-yl)quinolone-6,8-disulfonate, Quinoline yellow) at least in the material group one. 如請求項1所述的水膠組成物,其中,所述親水性單體具有丙烯醯基,並且所述輪烷分子與所述親水性單體的所述重量比例是介於1:6至1:94之間。 The water gel composition according to claim 1, wherein the hydrophilic monomer has an acryl group, and the weight ratio of the rotaxane molecule to the hydrophilic monomer is between 1:6 to Between 1:94. 如請求項26所述的水膠組成物,其中,所述輪烷分子中的所述環狀分子為α-環糊精(α-cyclodextrin)或β-環糊精(β-cyclodextrin),並且所述輪烷分子與所述親水性單體的所述重量比例是介於1:11至1:54之間。 The hydrogel composition according to claim 26, wherein the cyclic molecule in the rotaxane molecule is α -cyclodextrin ( α -cyclodextrin) or β -cyclodextrin ( β -cyclodextrin), and The weight ratio of the rotaxane molecule to the hydrophilic monomer is between 1:11 and 1:54. 如請求項26所述的水膠組成物,其中,所述輪烷分子中的所述環狀分子為羥丙基-β-環糊精(hydroxypropyl-β-cyclodextrin),並且所述輪烷分子與所述親水性單體的所 述重量比例是介於1:17至1:86之間。 The requested item aqueous gum composition according to 26, wherein the rotaxane molecule of the cyclic molecule is hydroxypropyl - β - cyclodextrin (hydroxypropyl- β -cyclodextrin), and the rotaxane molecule The weight ratio to the hydrophilic monomer is between 1:17 and 1:86. 如請求項26所述的水膠組成物,其中,所述輪烷分子中的所述環狀分子為(2-羥丙基)-γ-環糊精((2-hydroxypropyl)-γ-cyclodextrin),並且所述輪烷分子與所述親水性單體的所述重量比例是介於1:19至1:94之間。 The requested item aqueous gum composition according to 26, wherein the rotaxane molecule of the cyclic molecule (2-hydroxypropyl) - γ - cyclodextrin ((2-hydroxypropyl) - γ -cyclodextrin ), and the weight ratio of the rotaxane molecule to the hydrophilic monomer is between 1:19 to 1:94. 如請求項1所述的水膠組成物,其中,所述直鏈狀分子的所述平均分子量不小於4,000。 The water gel composition according to claim 1, wherein the average molecular weight of the linear molecule is not less than 4,000. 如請求項1所述的水膠組成物,其中,在所述輪烷分子中,所述環狀分子的外圍具有親水性官能基,並且所述環狀分子的內側具有疏水性空穴結構;其中,所述輪烷分子能通過所述環狀分子外圍的所述親水性官能基而與所述親水性單體作用,以使得所述輪烷分子在所述水膠組成物中分散。 The hydrogel composition according to claim 1, wherein, in the rotaxane molecule, the outer periphery of the cyclic molecule has a hydrophilic functional group, and the inner side of the cyclic molecule has a hydrophobic cavity structure; Wherein, the rotaxane molecule can interact with the hydrophilic monomer through the hydrophilic functional group on the periphery of the cyclic molecule, so that the rotaxane molecule is dispersed in the hydrogel composition. 如請求項1所述的水膠組成物,其中,所述輪烷分子的所述直鏈狀分子是以繞曲的型態分散在所述親水性單體中,至少一所述環狀分子的數量為多個,並且多個所述環狀分子是以串接的方式穿設在所述直鏈狀分子上。 The hydrogel composition according to claim 1, wherein the linear molecules of the rotaxane molecule are dispersed in the hydrophilic monomer in a tortuous form, and at least one of the cyclic molecules The number of the cyclic molecules is multiple, and a plurality of the cyclic molecules are arranged on the linear molecules in a series connection. 如請求項32所述的水膠組成物,其中,多個所述串接的環狀分子與其相鄰的多個所述串接的環狀分子能通過氫鍵的作用力彼此吸引、而以彼此堆疊的方式排列。 The hydrogel composition according to claim 32, wherein the plurality of cyclic molecules connected in series and the plurality of adjacent cyclic molecules in series can be attracted to each other by the force of hydrogen bonds, and Arranged on top of each other. 如請求項32所述的水膠組成物,其中,多個所述串接的環狀分子在所述直鏈狀分子上是以頭對頭(heads to heads)及尾對尾(tails to tails)的方式排列。 The hydrogel composition according to claim 32, wherein a plurality of the cyclic molecules connected in series are heads to heads and tails to tails on the linear molecules. Arranged in a way. 一種水膠鏡片,包括:一鏡片主體,其係由如請求項1至34中任一項所述的水膠組成物所形成。 A water gel lens, comprising: a lens body formed by the water gel composition according to any one of claims 1 to 34. 如請求項35所述的水膠鏡片,其中,所述輪烷分子至少分佈於所述鏡片主體的一凹弧面或一凸弧面上,以形成一輪烷分 子層,並且所述輪烷分子經配置負載一活性成分。 The hydrocolloid lens according to claim 35, wherein the rotaxane molecules are distributed on at least a concave arc surface or a convex arc surface of the lens body to form a rotaxane component Sub-layer, and the rotaxane molecule is configured to carry an active ingredient. 如請求項36所述的水膠鏡片,其中,所述活性成分包含:薄荷醇、樟腦、冰片、氯化鉀、鹽酸溶菌酶、甘草酸鉀、6-氨基己酸、硫酸鋅、維生素B2、氮磺酸鈉、磺胺甲噁唑、普拉洛芬、萘甲唑啉、四氫唑啉、三氯叔丁醇、鹽酸麻黃鹼、苯腎上腺素、維生素E、L-天門冬氨酸鉀、天門冬氨酸鎂、硫酸軟骨素、新斯明甲基硫酸鹽、精胺酸、維他命B12、維生素B5、維生素B6、維他命A、牛磺酸、苯海拉明、氯苯那敏、曲尼司特、硼酸、甘油、玻尿酸、多元醇、尿囊素的至少其中之一。 The hydrocolloid lens according to claim 36, wherein the active ingredient comprises: menthol, camphor, borneol, potassium chloride, lysozyme hydrochloride, potassium glycyrrhizinate, 6-aminocaproic acid, zinc sulfate, vitamin B2, Sodium nitrogen sulfonate, sulfamethoxazole, pranoprofen, naphazoline, tetrahydrozoline, chlorobutanol, ephedrine hydrochloride, phenylephrine, vitamin E, potassium L-aspartate , Magnesium Aspartate, Chondroitin Sulfate, Neosmine Methyl Sulfate, Arginine, Vitamin B12, Vitamin B5, Vitamin B6, Vitamin A, Taurine, Diphenhydramine, Chlorpheniramine, Trix At least one of nilast, boric acid, glycerin, hyaluronic acid, polyol, and allantoin. 如請求項35所述的水膠鏡片,其中,所述鏡片主體的一折射率(refractive index)介於1.315至1.598之間,所述鏡片主體的一可見光穿透率(light transmittance)不小於90%,所述鏡片主體的一含水率(water content)介於10%至75%(w/w)之間,所述鏡片主體的一動態接觸角(dynamic contact angle)不大於80度,並且所述鏡片主體的一延伸率(elongation)是介於250%至380%之間。The water gel lens according to claim 35, wherein a refractive index of the lens body is between 1.315 and 1.598, and a light transmittance of the lens body is not less than 90 %, a water content of the lens body is between 10% and 75% (w/w), a dynamic contact angle of the lens body is not greater than 80 degrees, and An elongation of the lens body is between 250% and 380%.
TW109141266A 2020-04-13 2020-11-25 Hydrogel composition and hydrogel contact lens TWI746286B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN202011398197.0A CN113527581A (en) 2020-04-13 2020-12-03 Aqueous gel composition and aqueous gel lens
JP2021058460A JP7140869B2 (en) 2020-04-13 2021-03-30 Hydrogel composition and hydrogel lens
US17/227,381 US20210315807A1 (en) 2020-04-13 2021-04-12 Hydrogel composition and hydrogel lens
EP21167820.6A EP3895693A1 (en) 2020-04-13 2021-04-12 Hydrogel composition and hydrogel lens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW109112349 2020-04-13
TW109112349 2020-04-13

Publications (2)

Publication Number Publication Date
TW202138471A TW202138471A (en) 2021-10-16
TWI746286B true TWI746286B (en) 2021-11-11

Family

ID=79601361

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109141266A TWI746286B (en) 2020-04-13 2020-11-25 Hydrogel composition and hydrogel contact lens

Country Status (1)

Country Link
TW (1) TWI746286B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201031699A (en) * 2009-01-07 2010-09-01 Lintec Corp Thermoresponsive polymer gel and thermoresponsive polymer gel film
CN102046662A (en) * 2008-05-30 2011-05-04 高级软质材料株式会社 Polyrotaxane, aqueous polyrotaxane dispersion composition, crosslinked body of polyrotaxane and polymer and method for producing the same
CN103254436A (en) * 2012-02-20 2013-08-21 翔升科技股份有限公司 Silicious prepolymer, and silicious hydrogel and contact lens prepared through using it
CN104968696A (en) * 2013-01-21 2015-10-07 住友精化株式会社 Composition for soft materials, and soft material

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046662A (en) * 2008-05-30 2011-05-04 高级软质材料株式会社 Polyrotaxane, aqueous polyrotaxane dispersion composition, crosslinked body of polyrotaxane and polymer and method for producing the same
TW201031699A (en) * 2009-01-07 2010-09-01 Lintec Corp Thermoresponsive polymer gel and thermoresponsive polymer gel film
CN103254436A (en) * 2012-02-20 2013-08-21 翔升科技股份有限公司 Silicious prepolymer, and silicious hydrogel and contact lens prepared through using it
CN104968696A (en) * 2013-01-21 2015-10-07 住友精化株式会社 Composition for soft materials, and soft material

Also Published As

Publication number Publication date
TW202138471A (en) 2021-10-16

Similar Documents

Publication Publication Date Title
Ali et al. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses
TW201302244A (en) Drug-carrying contact lens and manufacturing method thereof
Abdelkader et al. Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: Fabrication, mechanical properties, mucoadhesion, tolerability and stability studies
US11884779B2 (en) Ionically modified silicones, compositions, and medical devices formed therefrom
White et al. Controlled release of multiple therapeutics from silicone hydrogel contact lenses
Xu et al. Semi-interpenetrating network (sIPN) co-electrospun gelatin/insulin fiber formulation for transbuccal insulin delivery
JP2012517330A5 (en)
TW201026752A (en) Ionic silicone hydrogels having improved hydrolytic stability
TWI630931B (en) Ophthalmic lens and manufacturing method thereof
JP7140869B2 (en) Hydrogel composition and hydrogel lens
TW202009013A (en) Contact lenses with functional components and products thereof
US10023708B2 (en) Method of producing a delivery device
WO2008151019A1 (en) Extended release of bioactive molecules from silicone hydrogels
Kesavan et al. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system
CN107260655B (en) Vitamin E modified silicon-based hydrogel contact lens drug-loading system and preparation method thereof
JP2008509240A (en) Polymers and methods having continuous pores for drug delivery
Zhang et al. A nanocomposite contact lens for the delivery of hydrophilic protein drugs
TWI746286B (en) Hydrogel composition and hydrogel contact lens
CN115710329B (en) Flexible hydrophilic contact lens containing ectoin and preparation method thereof
Rathore Development and in-vivo in-vitro characterizations of Timolol maleate in-situ gels
Cagnetta et al. Reusable antimicrobial antibiotic-free dressings obtained by photopolymerization
Nief et al. Mucoadhesive oral in situ gel of itraconazole using pH-sensitive polymers: preparation, and in vitro characterization, release and rheology study
US20200166671A1 (en) Lipoic acid hydrogels
TWI812881B (en) Wet-packed soft hydrogel ocular inserts
CN114545658A (en) Preparation method of drug sustained-release type interpenetrating network hydrogel contact lens